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Abstract 
Background: Enhanced recovery after surgery (ERAS) is a perioperative multimodal 
approach with purpose to reduce surgical stress response and organ dysfunction, and 
thus to decrease the perioperative morbidity and length of hospital stay (LOHS). 
Randomized trials have shown that patients recover faster when traditions are altered, 
including extended information and guidance to patients, changes in analgesia and 
anaesthetic procedures, mobilisation procedures, and concerted effort by the 
department to reduce hospital stay. Although the benefits of ERAS on LOHS are 
recognized, the main causes for this reduction are not well understood.  
Objectives of PhD-work/research questions:  
1. We endeavoured to perform a controlled, randomized trial in which we 
compared patients treated by an ERAS approach with a special focus on counselling 
and guidance to patients treated in a standard traditional care pathway. The main 
objective of this study was to find whether we were able to decrease the total hospital 
stay (THS), primarily as a result of reduced morbidity (paper I).  
2.  A large part of patients with colorectal resections also need stoma. We wanted 
to examine whether pre- and postoperative stoma education within an ERAS 
programme can reduce the length of hospital stay, stoma-related complications, re-
admissions and improve health-related quality of life (HRQoL) (PaperII).  
3. Evaluate patients in various age groups in the ERAS care pathway, and 
examine whether elderly patients adhered to an ERAS program and achieved the 
same outcomes as younger patients (paper III). 
4. Assess additional insights into the impact of perioperative counselling and 
guidance when groups of patients are otherwise the same with respect to ERAS 
criteria (paper IV). 
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Results: Paper I showed that THS was significantly shorter in patients randomized 
to the ERAS care group than in patients randomized to the standard care group, 
although the two treatment groups had similar outcomes regarding 30-day mortality, 
major and minor morbidity, rate of reoperation, and readmissions. There were also no 
differences in postoperative C-reactive protein (CRP) levels, reflecting the 
inflammatory response, or the patients` tolerance of enteral nutrition. From this first 
study we cannot determine that one ERAS element is more effective than other 
interventions, but it suggests that accurate pre- and postoperative information and 
continuous guidance are important for the reduction in hospital stay. 
Paper II also showed a significantly shorter THS in the ERAS group with stoma 
education than in the standard care group. Regarding major and minor complications, 
stoma-related complications, re-admission rate, 30-day mortality and HRQoL, the 
two treatment groups had similar outcomes.  
Paper III investigated whether elderly patients may comply with the implementation 
of this multidisciplinary program, and whether they have better or worse outcome in 
an ERAS program than younger patients. This sub analysis showed that the 
adherence to the ERAS protocol was equally good in elderly and in younger patients. 
There were also no significant differences in THS in the different age groups treated 
in an ERAS program. 
Paper IV described a new randomized trial where we compared ERAS care plus 
extended counselling to ERAS care with standard counselling. The main result was 
that THS can be significantly reduced with extended pre- and postoperative 
counselling and guidance as an independent strategy. 
Conclusion: ERAS reduces the length of hospital stay in younger and older patients, 
as well as in patients receiving a planned stoma. The main reason for this reduction is 




The estimated numbers of surgical procedures performed world-wide each year are 
more than 320 million [1]. Operations on the colon and rectum, for both malignant 
and benign diseases, are among the most common operations performed in hospitals 
in the western world.  Colorectal cancer (CRC) is the second most common cancer in 
females and third in males, with 1.4 million new cases and 693.900 deaths globally in 
2012 [2] . European data from 2012 estimate 447 000 new cases and 215 000 deaths 
caused by CRC, which makes it the second most frequent  and second most deadly 
cancer in Europe [3]. Data from the Norwegian cancer registry shows that also in 
Norway CRC is the second most common cancer with an incidence of 4200 new 
cases per year, with an expected increase of 20% over the next 20 years. Only breast 
and prostate cancer are more frequent in females and males, respectively. Treatment 
of CRC has also been estimated to be the most expensive cancer to treat, costing 
approximately 1.6 billion NOK/ year[4]. 
Colorectal surgery has the largest group of patients treated at gastro-surgical 
departments in Norway. The use of healthcare resources and costs of elective 
colorectal surgery are associated with the length of hospital stay (LOHS) and the 
extent of postoperative morbidity. LOHS after elective colorectal surgery is usually 
6-12 days, and the complication rate varies between 10 and 50% [5-7]. Optimizing of 
health care is important especially in colorectal surgery where complications occur at 
a higher rate than most other surgical procedures, with a large impact on hospital 
costs [8].  
1.2 Standard traditional care 
Traditionally patients have been hospitalized after operations to observe and treat any 
surgical or anaesthetic complications that may occur, and in addition the patients  
should be back to a level of self-care before discharge [9]. Traditional perioperative 
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care and surgical training have been based on a master-trainee and hands-on 
experience, with surgeons-passed operative techniques and methods of perioperative 
care to residents [10].  These methods were generally accepted and considered 
successfully, although often not based on scientific evidence. Due to improved 
organizational structure within institutions and increased attention to surgical 
technique and performance, postoperative outcome improved [11-15]. However, 
patients where still suffering from morbidity, slow recovery and need for prolonged 
length of hospital stay. Standard elements in a traditional care pathway were fasting 
from midnight before surgery, preoperative bowel preparation, the use of nasogastric 
(NG) tubes and intra-abdominal drains, postoperative fasting, enforced bed rest and 
reduced mobilisation [10].  
A surgical patient is often examined and treated in several different departments in a 
hospital with different professional competencies, such as medical and surgical 
outpatient clinic, preoperative unit, operating room, postoperative recovery unit, 
surgical ward, and when necessary in other departments, without having  dedicated 
staff following the patient through the care pathway. Treatment in one unit affects the 
next [16]. An example is mechanical bowel preparation (MBP) which may lead to 
dehydration and electrolyte imbalance, which in turn causes that the anaesthetist must 
provide more intravenous (IV) fluids per operatively. Fluid overload may in turn have 
negative postoperative effect on gut function and possibly increase the risk of 
postoperative complications [17]. Another example is traditional opiate based 
anaesthesia and analgesia that often preclude early mobilisation and enforced enteral 
nutrition, as this requires a cooperating and fully awake patient. Premedication with 
long acting sedatives may also have additional effects on postoperative feeding and 
mobilisation. Already in the 1980s and 1990s, data suggested beneficial effects when 
allowing early feeding  postoperatively [18], without leading to approval or 
acceptance in surgical societies. Allowing nutrition postoperatively was also in 
conflict with two key cornerstones in traditional care; intestinal decompression via a 
NG suction and postoperative nil-by-mouth regimen. NG tubes were usually placed 
during surgery and kept in place until signs of postoperative ileus was gone, leading 
to significant patient discomfort [19]. The nil-by-mouth regimen, also 
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postoperatively, was probably adopted by surgeons trained in a tradition where 
aspiration was a feared complication [20]. Long lasting emesis and vomiting were 
common after former types of anaesthesia, especially chloroform and ether [21]. 
These factors, together with the use of intraabdominal drains and long lasting urinary 
catheterisation, also decreased the possibility of postoperative mobilisation.  
1.3 Enhanced recovery after surgery (ERAS) 
During the last two decades there has been an increased focus on optimal 
perioperative treatment and care. Different treatment modalities have been initiated 
with attempts to reduce postoperative LOHS, readmissions, reoperations and 
perioperative morbidity. The reasons for late recovery and discharge are complex. 
Organ dysfunction (surgical stress), postoperative pain, postoperative nausea and 
vomiting (PONV) and paralytic ileus are key elements, but many other factors, such 
as postoperative cognitive dysfunction, sleeping disorders, immobilisation and local 
hospital traditions like NG tubes, drains and urinary catheter postoperatively are also 
important. 
In Norway the University Hospital of North Norway in Tromsø, early started to give 
patients solid food the same evening or the day after surgery. Kehlet`s group at 
Hvidovre Hospital in Copenhagen has been a pioneer in systematic and controlled 
optimisation of the postoperative phase, by focusing on gut function, postoperative 
pain and mobility and combining interventions [22]. In a representative group of 60 
patients with open colon resections, 50% were discharged on the second 
postoperative day and 75% the third postoperative day. Over half of the patients had 
passage of stool within 24 hours, urinary catheter was removed the first postoperative 
day, and only 11% had to be catheterized an extra time. Complication rates were not 
higher than in other studies [23]. This group has later published similar results [24-
26] . An early prospective observational study, according to ERAS principles, from 
2000 to 2003 with 98 patients has been performed at our own hospital together with 
Haugesund Hospital. This study showed that 80% of patients were discharged on day 
5 with no differences in complication rates [27].  
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With increased recognition of the influence of perioperative practice and surgical 
trauma on the postoperative recovery, efforts were made to modify the surgical care 
pathway. ERAS or fast-track surgery is a multidisciplinary and  multimodal 
perioperative approach that aims to reduce surgical stress response and organ 
dysfunction, thereby reducing morbidity and length of hospital stay [28]. ERAS 
includes standardized preoperative, intraoperative and postoperative elements. The 
purpose of the preoperative ERAS elements are to optimize the patient before 
surgery, and includes patient information and counselling, avoidance or selective use 
of mechanical bowel preparation, avoiding prolonged fasting, carbohydrate loading, 
thrombosis prophylaxis and antibiotic prophylaxis. Intraoperative ERAS elements 
include anaesthesia techniques including epidural anaesthesia, operative technique 
including minimal invasive surgery, goal directed fluid management, prevention of 
hypothermia, and none or selective use of intraabdominal drains. Postoperative 
ERAS elements aim to enhance patient recovery and rehabilitation and include 
prevention of PONV, no NG tube, early removal of catheters and eventually drains, 
opioid sparing analgesia, enforced enteral nutrition and enforced mobilisation [29, 
30]. Examples of outcomes that are targeted and evaluated in an ERAS program are 
pain management, insulin resistance, return of gastrointestinal function, postoperative 
complications, length of hospital stay and return to normal daily routines [31]. There 
are 20 individual components described in consensus guidelines to the Enhanced 
Recovery After Surgery society[32], carried out by a multidisciplinary team of 
anaesthesiologists, surgeons, nurses and physical therapists. Guidelines in ERAS care 
were first described and published for colorectal resection and in recent times also for 
other procedures in gastrointestinal surgery, gynaecology and urology, and include 
around 20 perioperative elements. 
Several prospective studies have shown shorter hospital stay and less morbidity in 
ERAS care, but no difference in mortality. Some of the randomized controlled trials 
(RCT) to date have shown no difference in the complication rate [7, 33-41], while 
others have reported a difference in minor complications [42-45] (Table 1). There 
have been several meta-analyses and reviews analysing these RCTs. A Cochrane 
 18 
Review from 2011 stated, however, that the quantity and particularly the quality of 
the data are low [46]. 
 
First author (ref.) Year Patients (n) Numbers of ERAS items Reduced morbidity 
Delany et al. [34] 2003 64 4 No 
Anderson et al. [33] 2003 25 12 No 
Gatt et al.  [36] 2005 39 12 No 
Khoo et al. [38] 2007 70 8 No 
Ionescu et al. [37] 2009 96 10 No 
Muller et al. [42] 2009 151 9 Non-surgical 
Serclova et al. [43] 2009 103 10 Non-surgical 
Garcia-Botello et al. [35] 2011 119 9 No 
Vlug et al. [7] 2011 400 11 No 
Ren et al. [40] 2011 507 11 No 
Wang Q et al. [45] 2011 78 9 Non-surgical 
Wang G et al [44] 2011 210 8 Non-surgical 
Lee et al [39] 2011 100 5 No 
Wang Q et al [41] 2012 99 8 No 
Table 1: Randomised controlled trials comparing ERAS care to standard traditional 
care 
In Norway, the University Hospital of North Norway has been a pioneer hospital with 
members in the ERAS study group since its inception in 2001. This group has worked 
to develop ERAS through different stategies and interventions , but the 
implementetion across health care systems has been slow [16]. Also today the 
number of ERAS items used in clinical practice vary greatly between hospitals. 
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ERAS strategies are considered by most surgeons as “standard of care”,  and 
surgeons belive they are adhering to ERAS principles, but in fact they are mostly 
only using a "light" version. Adoption of ERAS care ouside clinical studies is 
probably variabel. Compliance with an ERAS protocol has been shown to be lower 
outside of a clinical trial [47]. Today most surgical departments in Norway use an 
ERAS “light” version in different degrees, and no one uses “traditional care”. “The 
“Norwegian National Guidelines  for diagnosis, treatment and follow-up of colon and 
rectal cancer” also declares ERAS as the standard of care in treatment of CRC [48].  
1.4 Stoma education and ERAS 
In Norway, about 14.000 people currently live with an entero- or colostomy, and 
about 1500 new stoma creations are carried out each year [49]. Delayed discharge 
after stoma formation is well-known in colorectal surgery [50-52]. The creation of a 
stoma will often be associated with both psychological and physical morbidity, which 
may be reduced by pre- and postoperative education of patients. It is recognized that 
a well-placed stoma improves independence in patient stoma care thus enabling the 
patients to earlier start up again with normal activities [53-55].   
Although education of patients receiving a new stoma is widely recommended, little 
data exist on the effect of educational interventions on stoma related complications, 
length of stay, and readmissions.  A systematic review of educational interventions 
for stoma patients found no consensus on the benefit of stoma education, although the 
grade of evidence was low [56].  The knowledge about patients with a planned stoma 
formation within an ERAS program is limited, since these patients mostly are not 
included in trials. In the literature there is only one randomised study with few 
patients evaluating stoma education as a part of an ERAS programme [34]. 
1.5 ERAS care in elderly patients 
The average age of the population is increasing and the surgical management of 
elderly patients is complex due to more comorbidity and reduced functional capacity. 
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More than 55% of patients with colorectal cancer are older  than 70 years and more 
than 26% are older than 80 years [4].  Age, comorbidities and poor nutritional status 
are identified causes of increased morbidity and delayed recovery after elective 
surgery [57-60]. Elderly patients are more often rejected for surgery, and in one 
report 21% of patients older than 85 years were not offered surgery, compared with 
4% in patients younger than 65 years, probably because of increased comorbidity or 
the older patients were thought to be unfit [61]. There is, however, a great 
heterogeneity concerning comorbidity and degree of mobility in elderly patients. 
Biological characteristics and not chronological age should be decisive for treatment 
and the choice of surgical intervention. The term frailty has been introduced. Frailty 
includes decreased reserves in general and deterioration in organ systems, but is not 
equivalent with comorbidity. Frailty may not exist in patients with considerably 
comorbidity. On the other hand, some elderly patients with little or no disease show 
to be frail [62]. Evaluation of frailty is important to avoid under and over treatment, 
which is a well-known pitfall in geriatric oncology [63]. A simple test to predict post-
operative outcome in frail elderly patients is not available. The best tool for 
preoperative evaluation in elderly patients is the Comprehensive Geriatric 
Assessment (CGA) [64, 65]. Even though the CGA is time-consuming, it seems to be 
reasonable to spend this extra time in identifying and correcting conditions in 
complex patients, which in turn may decrease surgical stress, length of hospital stay 
and postoperative complications.  
Studies have shown that ERAS is safe and reduces hospital stay in younger patients 
[29, 66]. For older patients, this age group has often either been excluded or numbers 
have been too small for subgroup analysis [67]. There is uncertainty whether elderly 
patients can carry out such a multimodal program and whether they have worse or 
better outcomes than their younger counterparts. There has also been a fear that early 
postoperative feeding and enforced mobilisation is too hazardous for elderly patients 
[68]. However, patients at risk and elderly patients may especially benefit from this 
multimodal approach to avoid organ dysfunction, enhance recovery and reduce 
perioperative morbidity. A systematic review from 2014 [67] found that ERAS both 
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reduced hospital stay and the occurrence of complications in elderly patients in two 
randomized controlled trials [45, 69], and in the majority of the observational cohort 
studies  no differences between younger and elderly patients were found. However, a 
considerably variation was found in the definitions of elderly in the studies included 
in the review, ranging from ages >65 to >80 years [67].  
 
1.6 ERAS interventions 
 
ERAS flow chart 
 
Figure 1 ERAS flow chart. Adopted from Ljungqvist, Scott, Fearon, JAMA 
Surgery, 2017.  With permission from Olle Ljungqvist. 
 
1.6.1 Perioperative counselling 
Included in the term “counselling” are preoperative information and education, as 
well as postoperative guidance. Preadmission information and counselling are 
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considered as core factors in an ERAS protocol, even if the evidence levels are 
considered low [32, 70]. Patients should be informed preoperatively about the course 
of the operation, the postoperative care plan and expected hospital stay, and discharge 
criteria. Information regarding postoperative pain control, mobilisation and oral 
intake should be described. Detailed information about anaesthetic and surgical 
procedures may reduce anxiety and fear, and enhance postoperative recovery with 
reduced length of hospital stay [71-75]. Personal counselling or multimedia 
information including information of the course of the procedure with expectations 
and tasks to patients may improve pain control, early postoperative mobilisation, pre- 
and postoperative feeding, and respiratory physiotherapy, and thus reduce 
complications [76-79]. However, patient education and counselling as  independent 
strategies for enhanced recovery and reduced length of hospital stay have received 
little attention and there are no randomised trials reported in the literature addressing 
counselling specifically in general or colorectal surgery as such. 
1.6.2 Preoperative optimisation / prehabilitation 
The preoperative medical evaluation with history-taking and physical examination is 
important in order to identify medical conditions and risk factors for perioperative 
morbidity and postoperative mortality.  Ancillary studies should be performed for 
individual indications [80]. Excessive testing can cause delays in treatment and 
unnecessary and possible harmful treatments and also anxiety in patients, and routine 
testing should be abandoned and rather ordered selectively [81-83]. Factors like 
cigarette smoking, alcohol consumption (>3 units /day), anaemia (Hb <7 mmol/l), 
diabetes mellitus (DM), poor nutritional status and American association of 
anaesthesiologists (ASA ) grade III are all shown to be independent risk factors for 
complications in colorectal surgery, and optimisation improves outcomes  [84-88]. 
Four to eight weeks smoking cessation prior to surgery reduces postoperative 
complications and morbidity significantly [89]. Malnourished patients benefit from 
preoperative nutritional supplementation with fewer anastomotic leaks and infectious 
complications [70, 90]. The duration of supplementation will depend on the severity 
of malnutrition [91]. 
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Even in the absence of postoperative complications, major surgery is associated with 
20-40 % reduction in functional and physiologic capacity, which has been measured 
by energy expenditure, endurance time, workload, and heart rate during maximum 
exercise [92, 93]. Efforts to improve outcomes have primarily focused on the 
peroperative and postoperative period, but the preoperative period is probably a better 
time to make changes in patient’s lifestyles and to enhance the functional capacity to 
enable the patients to withstand the surgical stress. The concept of prehabilitation is a 
multidisciplinary programme, which includes preoperative physical exercise, 
nutritional support and psychological support, to increase functional capacity in 
anticipation of the upcoming surgical stress. There seems to be a clear benefit of 
prehabilitation programmes on postoperative functional capacity, but it is still not 
demonstrated regarding other postoperative outcomes [94]. 
1.6.3 Preoperative fasting  and carbohydrate loading (CHL) 
Fasting from midnight was for many years standard practice and was intended to 
reduce aspiration at the induction of anaesthesia. There has, however, never been a 
scientific backup for this dogma [95]. A Cochrane review of 22 RCTs found no 
evidence of an increased risk of aspiration or related morbidity in patients who were 
allowed free intake of clear fluids until 2 hours before anaesthesia and surgery, 
compared with the standard fasting from midnight policy [96]. Most guidelines have 
also stated that clear fluids are safe to take up to 2 hours and solids up to 6 hours 
before elective surgery  [97, 98]. 
Postoperative insulin resistance is an indirect expression of the metabolic response to 
surgical stress, resulting in reduced insulin stimulated glucose uptake, increased 
glucose release and hyperglycaemia [99, 100]. Hyperglycaemia may in turn lead to 
prolonged recovery and postoperative complications [101]. Preoperative carbohydrate 
loading has demonstrated reduced insulin resistance, and to maintain and improve 
whole-body protein balance and muscle functions [100, 102, 103]. There have been 
more than 30 RCT investigating the effect of CHL on improved postoperative 
outcomes, and these studies have been summarized in three meta- analyses [104-106] 
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and one Cochrane review [107]. Both the most recently published and  the most 
robust meta-analysis found that CHL caused a small reduction in length of hospital 
stay compared to fasting, and no benefit on length of stay or complications when 
compared with water or placebo[104]. 
1.6.4 Preoperative bowel preparation 
Mechanical bowel preparation (MBP) alone, prior to elective colorectal surgery, 
should be abandoned and the evidence is consistent and robust [108, 109]. MBP 
without oral antibiotics does not give any beneficial effects on outcomes and may 
even be harmful due to the risk of fluid and electrolyte disturbances [110-112]. Most 
national guidelines follow this advice recommending abandonment of MBP [113]. 
The Enhanced Recovery After Surgery Society also recommends either no or 
selective use of MBP [32, 70]. Nevertheless, MBP has been used extensively in 
colorectal surgery [114]. This may be due to other benefits as improved detection of 
smaller tumours and polyps, possibility for on table endoscopy and generally easier 
bowel handling [115]. However, previously several studies could demonstrate 
benefits of non-absorbable broad-spectrum oral antibiotics in combination with 
mechanical bowel preparation (OAMBP) in elective colorectal surgery. The use of 
OAMBP reduced the incidence of surgical site infections (SSI), non-SSI 
complications including anastomotic leak, postoperative ileus and also reduced the 
length of hospital stay[116-119]. The benefit or harm of MBP is a subject with great 
controversy in the literature, but the evidence today supports OAMBP in combination 
with IV antibiotics at induction of surgery [109]. 
1.6.5 Thrombosis prophylaxis 
Major abdominal surgery implies a high risk of venous thromboembolism (VTE). 
VTE-prophylaxis is well established to reduce the incidence of deep vein thrombosis 
(DVT) , pulmonary embolism (PE) and mortality [120]. Graduated compression 
stockings give additional reduction [121].  Meta-analyses have not found differences 
between perioperative thromboprophylaxis with low molecular weight heparin 
(LMWH) or unfractionated heparin (UFH) regarding mortality, major or minor 
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bleeding, or thromboembolic outcomes [122]. Controversies in recent years have 
been whether patients should have only in-hospital or extended 4 weeks 
antithrombotic prophylaxis. A Cochrane review from 2009 stated that prolonged 
thromboprophylaxis significantly reduced the risk of VTE compared to in-hospital 
prophylaxis only, in major abdominal and pelvic surgery without increased bleeding 
complications [123]. However, only 4 studies were found eligible for inclusion in this 
analysis. No randomized controlled trial has been able to demonstrate a reduction in 
clinical variables as symptomatic DVT, symptomatic PE or mortality in prolonged 
prophylaxis. They have only shown a reduction in asymptomatic screening detected 
DVT [124-126]. Current guidelines vary somewhat, but mostly they recommend 4 
weeks prophylaxis, or state that it should be considered or recommended particularly 
in high risk patients (prior VTE, anaesthesia >2 hours, bed rest greater than 4 days, 
age>60 years, advanced stage cancer disease) [127, 128].  
1.6.6 Premedication 
Long active sedatives have traditionally been used to reduce patient anxiety and calm 
down the patients before entering the operating room. To reduce anxiety, 
benzodiazepines are frequently used, but they also causes drowsiness, amnesia and 
cognitive impairment [129]. In a recently published RCT, patients with various 
elective surgeries were randomized to lorazepam, placebo or no premedication. 
Lorazepam did not improve patient satisfaction, and was associated with extended 
time to extubation and lower rate of early cognitive recovery [130]. Premedication 
with long acting sedatives may also have additional effects on postoperative feeding 
and mobilisation. A Cochrane review from 2009 evaluating premedication on anxiety 
in adult day-surgery under general anaesthesia found no evidence of different time to 
discharge in patients receiving premedication [131]. Other anxiolytics, such as 
clonidine and melatonin, have shown to have opioid sparing effects in addition to 
anxiolytic effect [132]. Clonidine is associated with sedation and hypotension, but 
melatonin offers an atoxic alternative to benzodiazepines, and in meta-analysis 
melatonin may be equally effective in reducing preoperative anxiety, compared to 
standard treatment with midazolam [133]. In summary, traditional long acting 
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sedatives delay immediate postoperative recovery and should not routinely be used 
before surgery. 
1.6.7 Antimicrobial prophylaxis 
Already in the 1960s and 70s firm evidence existed that prophylactic IV antibiotics 
reduced postoperative surgical wound infections (SWI) in colorectal surgery [134, 
135]. Prophylactic IV antibiotics are now routinely used in colorectal operations 
within 60 minutes prior the operation, and should include both anaerobic and aerobic 
coverage. Repeated doses may be beneficial in prolonged procedures, but there is 
generally acceptance that continuation of treatment does not give any supplemental 
benefit [113]. The national guidelines in Norway today recommend oral antibiotics 
with high bioavailability alone, 2 hours before surgery, and acts as a systemic 
prophylaxis and not as a selective decontamination of the digestive tract (SDD) [136]. 
However, data on the use of oral antibiotics alone are lacking [113]. A meta- analysis 
from 2011 and a recent Cochrane Review from 2014 showed a significant reduction 
in SWI when oral and IV antibiotic prophylaxis were combined compared to IV alone 
[137, 138]. Oral antibiotics given as SDD should be broad spectrum and non-
absorbable and optimally given as supplement to MBP.  
1.6.8 Anaesthetic protocol 
There is no good evidence to determine different general anaesthetic techniques. It is 
rationally wise to use short acting agents like propofol in combination with fentanyl 
or remifentanil instead of long-acting IV opioids, to promote recovery. Most 
commonly, inhalational anaesthetics such as isoflurane, sevoflurane or desflurane are 
used in combination with propofol and fentanyl/remifentanil. Total intravenous 
anaesthesia (TIVA) with propofol and remifentanil without gas may be beneficial in 
patients when suspecting PONV [32]. In an experimental porcine model during 
cardiopulmonary bypass surgery, isoflurane significantly increased fluid shift from 
intravascular to interstitial space, in contrast to propofol. The resulting tissue/organ 
oedema may have negative effect on vital organ functions [139]. Depth of anaesthesia 
should be monitored by Bispectral Index (BIS) to titrate anaesthetics drugs to a 
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minimum, and avoid complications like cognitive dysfunction in elderly [140]. Long-
acting neuromuscular blockade agents (NMBA) should be avoided, and always when 
using NMBA, neuromuscular function should be monitored [141].  
1.6.9 Prevention of hypothermia 
Perioperative hypothermia (body core temperature <36˚C)  is common in patients 
undergoing surgery with incidence reported as high as 70% [142]. Risk factors are 
prolonged surgery, extremes of age (neonates and elderly), extensive burns, 
preoperative low body temperature and severe trauma [143]. A systematic review and 
meta-analysis found that clinically relevant hypothermia starts with body core 
temperature <36˚C, and hypotherm patients have shown to have increased SSI and 
morbid cardiac events. Hypothermia inhibits coagulation, impairs drug metabolism, 
extends post- anaesthesia recovery and prolongs hospitalization [144]. Skin surface 
pre-warming is effective in preventing hypothermia and pre-warmed patients often 
report less anxiety and greater comfort with their surgical experience [145, 146]. 
Maintaining normothermia during surgical procedures is necessary and can be 
achieved by forced air warming, resistive heating blankets or circulating water 
garments devices. Among these methods, forced-air warming is most effective and 
safest [143]. IV fluids should be warmed (37˚C). Body temperature should be 
monitored peroperatively to titrate warming and also to prevent hyperpyrexia.  
1.6.10 Perioperativ fluid management 
Fluid therapy has been a controversial aspect of perioperative care over years. On the 
one hand too little fluid may cause hypovolaemia with possible hypo-perfusion of 
vital organs and the bowel. On the other hand too much fluid may lead to increased 
interstitial lung fluid and bowel oedema, which in turn also may lead to complications 
[32, 147]. Historically, practice in standard care has been providing IV fluids in 
volumes in excess of actual perioperative losses. Traditional regimens with volumes 
of 3.5 to 7 litres IV fluid on the day of surgery and more than 3 litres the following 
postoperative days can lead to 3-6 kg weight gain [148, 149].  Some randomized 
controlled trials have demonstrated that fluid restriction in colorectal surgery is 
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associated with reduction in morbidity and hospital stay [148, 150] while other 
studies have indicated no difference [17, 151]. Definitions of what is “restricted” and 
“liberal” have, however, varied substantially between the studies. In a meta-analysis 
Vardahan concluded that fluid volume delivered rather should be classified in “fluid 
balance” (between 1.75 and 2.75litres/d) or “fluid imbalance” (restricted < 1.75 
litres/d or liberal >2.75 litres/d fluid therapy). When “restricted” fluid regimens were 
compared to” standard” or “liberal” fluid regimen there were no differences in length 
of stay or complications, but when reclassified to fluid balance or imbalance there 
was a clear difference in favour of fluid balance [147].  To optimize and individualise 
the perioperative fluid therapy, a number of methods have in recent years been used, 
e.g. transoesophageal Doppler (TED), to measure intraoperative stroke volume and 
cardiac output in order to deliver an intraoperative goal-directed fluid therapy 
(GDFT). In a recent meta-analysis GDFT had no effect on mortality, morbidity or 
length of stay when considered in the settings of ERAS pathways, compared to 
controls. When considered in a traditional care pathway, there was however a 
reduction in morbidity and length of stay [152]. A randomized controlled study of 
patients undergoing open colorectal surgery in our hospital found similar morbidity in 
the group treated with Central Venous Oxygen Saturation (ScvO2)-guided, restricted 
fluid therapy, as in the control group [153]. Individualised fluid therapy is, however, 
a main component of modern ERAS care. Intravenous fluid postoperatively should be 
minimised and a return to oral fluids the day of surgery or first postoperative day 
should be sought.  
1.6.11 Epidural anaesthesia (EDA) / Postoperative analgesia 
Postoperative pain management is recognized as a key factor in patient recovery after 
surgical procedures. It is not only important for pain relief, but also to ensure that 
patients can start with early mobilisation and feeding. Postoperative pain relief with 
EDA has been shown in open surgery to have a positive effect on bowel function, 
food intake and out-of-bed mobilisation, which results in improvement in quality of 
life [154]. EDA has shown to reduce the postoperative period of ileus, but only when 
opiate-free epidural was used [155]. There is, however, no evidence that EDA 
 29 
improves outcomes such as reduced LOHS, postoperative morbidity or mortality in 
colorectal surgery [156]. The benefit of EDA is therefore controversial, especially in 
minimal invasive surgery, where it has not proven to be more effective than other 
analgesic techniques. A review article from 2012 stated that routine use of EDA in 
laparoscopic surgery cannot be recommended [157]. A recent RCT concluded that 
EDA after laparoscopic colorectal resections rather impeded recovery [158]. The 
optimal duration of EDA in open surgery is 2-3 days [32].  
Other analgesic techniques described are the use of spinal analgesia, lidocaine 
infusion during and after surgery, intraperitoneal instillation of long acting 
anaesthetics and transversus abdominis plane (TAP) block. Most of these techniques 
are not routinely used, and due to lack of evidence, also not recommended [157]. 
Infiltration with local anaesthetic of the surgical wound can provide excellent 
analgesia and is recommended. 
Non opioid analgesics as paracetamol and nonsteroidal anti-inflammatory drugs 
(NSAID) are important components to reduce opioid-related adverse effect on 
recovery [159, 160]. However, there is conflicting evidence regarding the adverse 
effect of NSAID use with anastomotic healing in colorectal surgery. The latest 
updated meta-analysis concluded that data strongly suggest a link between 
postoperative NSAID and anastomotic leak [161]. Subsequent studies have shown 
both an association with anastomotic leak [162, 163] (one study for diclofenac only) 
and no significant association with anastomotic leak [164, 165]. Whether NSAID use 
is a clinically relevant risk factor for anastomotic leakage still requires further studies, 
but some caution is certainly justified. 
Glucocorticoids (dexamethasone or methylprednisolone) have shown to reduce 
postoperative pain and nausea, as well as length of stay with no increased 
complications [166, 167], and should be considered as a part of the multimodal 
analgesic strategy in both open and minimal invasive surgery.  
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1.6.12 Minimal invasive surgery 
Large trials comparing open and laparoscopic surgery have demonstrated reduced 
length of hospital stay and postoperative pain for laparoscopic procedures [168-171]. 
The only randomised trial found in the literature comparing the four combinations of 
standard or ERAS care with laparoscopic or open surgery is the Dutch LAFA trial 
[7]. This study reported significantly shorter total hospital stay (THS) among patients 
randomized to the laparoscopic/ERAS group, but no differences between the four 
treatment groups regarding morbidity, readmission or quality of life. Laparoscopy 
was also found to be the only independent factor that significantly reduced THS. The 
EnROL trail, which also included rectal surgery, found a significantly reduction in 
length of stay in laparoscopic surgery and ERAS compared to open surgery and 
ERAS, but no differences in other outcomes [172]. Short term outcomes of robotic 
surgery are comparable to standard laparoscopy [173].  
1.6.13 Use of nasogastric (NG) tubes, abdominal drainage and 
urinary drainage 
Three meta-analyses in different time periods have all concluded that routine NG 
decompression should be avoided because the risk of atelectasis, pneumonia and 
fever is reduced in patients without NG tubes. No routine NG decompression 
improves bowel function and reduces discomfort and LOHS [174-176].  
Intraperitoneal drains after colonic surgery do not reduce postoperative complications 
like anastomotic leakage or SWI, reoperation or mortality [177, 178] and should not 
be used routinely because it reduces mobilisation. In rectal surgery there is more 
controversy. A systematic review and meta-analysis from 2013 concluded that the 
presence of a pelvic drain reduces anastomotic leakages and the rate of 
reinterventions after low anterior resections (LAR) [179]. The results were, however, 
only supported by the data from 5 non RCTs. Subgroup analyses of 3 RCTs could not 
find any benefits for pelvic drainage. A recently published RCT with more than 460 
patients could not show a decrease in neither the risk of pelvic sepsis, time to 
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diagnosis, nor the risk of reoperation in the patients with pelvic drain after LAR 
[180].  
The duration of transurethral catheterisation should be as short as possible, as 
prolonged catheterisation is associated with increased risk of urinary tract infection 
(UTI). In one study early removal of bladder catheter the morning after thoracic or 
abdominal  surgery significantly reduced the risk of UTI compared to prolonged 
catheterisation of 3-5 days until the EDA was discontinued [181]. The same study 
showed no difference in urinary retention. Urinary drainage is not necessary for the 
duration of EDA and can be removed the morning after surgery [182]. In rectal 
surgery it has been assumed that nerve damage due to pelvic dissection results in 
more urinary retention. Also after pelvic surgery there are no benefits of prolonged 
catheterisation compared to removal first postoperative day [183, 184]. One study, 
however, found an increased risk of retention in patients with low rectal carcinoma 
[183]. Suprapubic compared to transurethral catheterisation after abdominal surgery 
has been investigated in several trials, and a meta-analysis of these trials found 
significantly more bacteriuria and patient dissatisfaction in patients with transurethral 
catheterisation [185].  However, all patients had 4-7 days of urinary drainage and the 
urinary catheter was not removed the first or second postoperative day as 
recommended today. Routinely use of suprapubic catheterisation is not 
recommended, but could be used in patients with increased risk of postoperative 
urinary retention. 
1.6.14 Enforced postoperative mobilisation 
Bed rest and reduced mobilisation is believed to be an important factor for 
postoperative morbidity. The rationale is that enforced mobilisation reduces risk for 
thromboembolic complications, prevents cardiovascular and muscle deconditioning, 
and stimulates gastrointestinal recovery [186-188]. There are several studies 
supporting an association between early mobilisation and postoperative outcomes, but 
a systematic review found that the results of these studies are conflicting and the 
study quality was poor [189]. In a recently published RCT staff-directed facilitation 
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of early mobilisation in an ERAS program did not improve outcomes as recovery of 
walking capacity, recovery of gastrointestinal function, complications or readiness for 
discharge [190]. Both study groups were a part of an ERAS program, and indicated 
that further targeted mobilisation that already is a part of the program had no impact 
on outcomes. Although the evidence level is weak, the recommendation grade in the 
ERAS society guidelines are strong, due to reduced risk of pneumonia, muscle 
weakness and insulin resistance [32, 70].   
1.6.15 Enforced postoperative feeding 
Early oral nutrition after major gastrointestinal surgery is safe and a Cochrane review 
found indications that early postoperative feeding reduces the risk of postoperative 
complications [191]. There might be an increased risk of vomiting and other efforts to 
prevent postoperative paralytic ileus have to be taken into account. Also a newer 
meta-analysis comparing early oral feeding vs. traditional delayed feeding in 
colorectal surgery found that early oral feeding is safe and reduces LOHS and total 
complications [192]. Oral nutritional supplement (ONS) to achieve targeted intake of 
protein and energy may be used more extensively, but probably in more selected 
patient groups, e.g. patients with malnutrition or unplanned weight loss. It has been 
shown in malnourished patients that postoperative ONS improved nutritional status, 
quality of life, and morbidity [193]. Also in patients without malnutrition it could be 
demonstrated a reduction in postoperative weight loss and incidence of minor 
complications [194]. ONS from the day before surgery and at least the first four 
postoperative days is recommended in ERAS guidelines [32]. 
1.6.16 Periopertaiv glycaemic control 
 Hyperglycaemia is common after major surgery and is present in as many as 20% to 
46% in non-diabetic patients and 24% to 72% in diabetic patients [195]. An 
association between perioperative hyperglycaemia and postoperative complications 
has been recognised in almost every surgical speciality. One study of patients with 
and without DM after general surgery found that perioperative hyperglycaemia 
increased the risks of adverse events. Non-diabetic patients had nearly twice the risk 
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of reoperative interventions, infections and of hospital deaths as patients with DM 
[196]. This was confirmed in another recent study. Non-diabetic patients with 
hyperglycaemia had more adverse events than patients with DM [197].  Kiran et al 
described a high incidence of postoperative hyperglycaemia in non-diabetic patients 
undergoing colorectal surgery. Even only a single episode of elevated glucose 
postoperatively was associated with complications and increased mortality, and the 
risk was related to the degree of elevated glucose [198]. They recommended 
monitoring of glucose postoperatively in order to take action for glycaemic control 
even in patients without DM. However, most of these studies were not done within an 
ERAS setting. Several ERAS elements affect glucose levels and insulin resistance, 
and thereby improve glycaemic control without giving insulin, which carries the risk 
of hypoglycaemia in a ward setting [32, 199].  
1.6.17 Prevention of postoperative ileus (POI) 
Prolonged postoperative ileus (POI) is a major problem after colorectal surgery, with 
a reported incidence between 10% and 30% [200, 201], and has been associated with 
a large increase in LOHS [202].  A number of the above listed measures help to 
reduce the incidence of POI such as thoracic EDA in open surgery, avoidance of 
nasogastric decompression, prevention of fluid overloading intra- and 
postoperatively, and minimal invasive surgery. Increased adherence to an ERAS 
protocol helps to prevent POI, but still almost 25% of patients needed a NG tube in a 
well-established ERAS pathway in one study [203]. No prokinetic drug has proven to 
be effective in treating POI, but the use of magnesium has been evaluated in two RCT 
after abdominal and colorectal surgery with effect on POI in one study [204] and no 
effect in the other [205]. Other interventions as chewing gum and coffee 
consumptions have in RCT shown to have positive effect on POI [206, 207].  
1.6.18 Prevention of postoperative nausea and vomiting (PONV) 
PONV is common and affects approximately 30% of patients after anaesthesia and 
surgery [208]. There are many risk factors for developing PONV, like patients related 
factors (previous history of PONV, non-smoking status and female gender), 
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anaesthetic related factors (inhalation agents, opioid use) and surgical factors (long 
duration of surgery) [209]. If more than two risk factors are present, a multimodal 
approach to reduce PONV should be conducted, which includes both 
pharmacological and no-pharmacological therapies  [32]. Minimizing anxiety is 
important and can be achieved with information and counselling. Other factors like 
adequate preoperative hydration, minimal preoperative fasting and carbohydrate 
loading may also reduce the incidence of PONV. Preoperative dexamethasone has 
both positive effects on PONV and postoperative pain [210]. TIVA with propofol, 
compared to gas anaesthesia, reduces the incidence of PONV [209]. Increased use of 
opioids intra- and postoperatively are associated with higher incidence of PONV 
[211].  Antiemetic drugs act on at least four different receptor systems; cholinergic, 
dopaminergic (D2), histaminergic (H1), and serotonergic (5HT3) [208].  The most 
commonly used are metoclopramide (dopamine antagonist), ondansetron (serotonin 
antagonist), droperidol (dopamine antagonist) and meclizine (antihistamine).  All of 











1.7 Rational for further ERAS care research  
The hypothesis of an ERAS program is that the total sum of all implemented 
measures affects the surgical stress response.  There are about 20 items included in an 
ERAS program. Many argue that only a rigid adherence to an ERAS program can 
provide the proposed benefits, citing studies showing that the more ERAS elements 
are implemented, the more frequently the postoperative course is improved [213, 
214]. For several of these individual components it has been discussed whether they 
have effect alone. Some examples are omission of MBP compared to MBP in 
combination with oral antibiotics, individualized analgesic approach without EDA in 
laparoscopic surgery, preoperative carbohydrate loading, and different fluid protocols 
where the optimal approach still is unclear.  
Several different outcome measures have been reported, like LOHS, return of gut 
function and morbidity. The LOHS when evaluating the effectiveness of ERAS is 
questionable, especially in elderly patients where discharge to home and return to 
baseline function is more unlikely. Postoperative complications are, from the 
surgeon’s perspective, the most important outcome of recovery. Early discharge 
should not be a goal in itself. The main goal of ERAS should be to reduce morbidity 
and thereby reduce the length of stay. Shorter LOHS will though, have major 
financial consequences for the community in providing effective health care with 
high quality. One important question is why ERAS care reduces LOHS although 
most of the RCT’s do not show reduced morbidity. Furthermore, none of the RCTs or 
meta-analysis have shown differences in major complications or mortality [46, 215]. 
Is the reduced LOHS due to improvement in postoperative functional status, or due to 
the patient’s mental preparations and information about the course of the operation?  
Or is it related to changes in organization of care and not necessarily due to improved 
physiological recovery as proposed in a study by Maessen et al [216].  
Haukeland University Hospital started early with the introduction of ERAS, where 
the Department of Gastrointestinal Surgery performed an observational study already 
from 2000-2003, comparing standard care to ERAS care. After this study, the plan 
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was to conduct an RCT, but was never completed before we took up this work in 
2010. We endeavoured to conduct a controlled, randomized trial in which patients 
treated by the best possible multimodal approach (ERAS) were compared to patients 
treated in a conventional standard care pathway used at that time. The main goal of 
the first study was to determine whether we were able to decrease LOHS, mainly as a 
result of reduced morbidity [217].  
A large proportion of the patients included in this RTC had a planned stoma as part of 
their surgical treatment. All patients with a planned stoma in the ERAS care arm of 
the RCT also had preoperative stoma education. There is little evidence that stoma 
education improves outcomes in these patients, especially within an ERAS program. 
Elderly patients have in many ERAS studies either been excluded or the patients have 
been too few to perform subgroup analyses. There is uncertainty whether elderly 
patients can comply and adhere to this multidisciplinary program, and if they have 





2. Aims of the thesis 
 
There are two main objectives of the study: 
1) Determine if an ERAS care pathway can reduce the total length of hospital 
stay (THS), and reduce postoperative morbidity. 
 





Paper I:  
The aim of this study was to evaluate patients receiving colorectal resection within an 
ERAS care pathway compared to standard traditional care. We wanted to determine 




In this sub-study we wanted to compare patients receiving a planned stoma within 
ERAS care and standard care. We wanted to evaluate whether stoma education within 
an ERAS program can reduce THS and stoma related complications, and improve 
health related quality of life (HRQoL), compared to traditional standard care and 





In this sub-study, the aim was to evaluate patients in different age groups in the 
ERAS care and find out whether elderly patients attained the same outcome-results as 
younger patients. We also wanted to evaluate adherence to an ERAS program in 
elderly patients compared to younger patients. 
 
Paper IV: 
In this RCT patients who received ERAS care with extended pre- and postoperative 
counselling were compared to patients who received ERAS care with standard 
counselling. The aim was to evaluate whether counselling alone could decrease THS. 
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3. Materials and methods 
3.1 Paper I: ERAS care vs. standard traditional care 
The patients included in paper 1 to 3 derive from the same randomized controlled 
trial which was conducted at Haukeland University Hospital in the time period 5th 
January 2012 to 4th March 2015. 
Adult patients, who were scheduled for elective open or laparoscopic colorectal 
surgery (malignant or benign diseases), with or without stoma, could be included in 
the study. After thorough information, both orally and in writing, written consent was 
obtained. Exclusion criteria were emergency operations, pregnancy, impaired mental 
capacities, inability to adapt to the ERAS criteria, ASA IV and if a multi-visceral 
resection was planned. 
Randomization 
Patients were block randomized to ERAS or standard care with an allocation ratio of 
1:1, and an independent statistician prepared the sequence in advance. Due to the 
nature of the trail, neither the patient nor the physician were blinded to the treatment 
assignment. 
Objectives and end points 
THS was the primary outcome measure and was defined as postoperative hospital 
stay (PHS), plus additional readmission days within the first 30 days after surgery. 
Prior to study commencement discharge criteria were defined: (1) no complications 
requiring treatment in hospital, (2) postoperative pain adequately controlled with oral 
medication (VAS <4), (3) bowel function (faeces or repeated flatus) and (4) 
mobilized and out of bed more than 6 hours each day. Patients who received a stoma 
should be satisfied with their stoma care before discharge. Secondary end points were 
postoperative complications, PHS, postoperative C-reactive protein (CRP) levels, 
readmission rate, HRqoL (stoma patients) and mortality.  
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Perioperative care  
The ERAS elements used in the two treatment groups in the study, appear in Table 1. 
The two treatment groups were admitted to separate wards during hospitalization. 
Patients who were randomized to the ERAS group were treated to the ward`s best 
ability in accordance with ERAS consensus guidelines [32, 70]. Patients randomized 
to the standard treatment group were treated as they had been earlier after colorectal 
resections. As some ERAS items already were considered as standard of care, some 
items were included in this treatment group as well. 
Table 1 Numbers of ERAS items used in both groups [217] 
 ERAS care Standard care 
Preoperative   
   Preoperative counselling Ѵ  
   Preoperative feeding Ѵ  
   Carbohydrate loading Ѵ  
   No bowel preparation   
   No premedication Ѵ  
   Antimicrobial prophylaxis Ѵ Ѵ 
Perioperative   
   Fluid restriction Ѵ  
   Anaesthetic protocol TIVA Gas 
   Prevention of hypothermia Ѵ Ѵ 
   Epidural anaesthesia Ѵ Ѵ 
   Minimal invasive incisions   
Postoperative   
   No routine use of nasogastric tubes Ѵ Ѵ 
   No use of drains in colon surgery Ѵ Ѵ 
   Enforced postoperative mobilisation Ѵ  
   Enforced postoperative feeding Ѵ  
   No systemic morphine use Ѵ  
   Standard laxative Ѵ  
   Early removal of urine catheter Ѵ  
Total number 16 5 





3.2 Paper II: Stoma education within an ERAS program 
In this sub-study, we examined patients who would receive a planned stoma as part of 
their surgical treatment and who would presumably manage their stoma before 
discharge. Stoma patients were also examined with regard to HRQoL, evaluated with 
the 15D instrument (http://www.15d-instrument.net/15d). This is a self-administered, 
standardized health state descriptive questionnaire, also validated and translated into 
Norwegian, and can be used both as a single index and a profile score measure [218].   
All patients who were to have a planned stoma in the ERAS group had one or two 
consultations before surgery with the stoma and ERAS nurse specialist. They 
received thorough information about what stoma implies and were trained in stoma 
care preoperatively, while patients in the standard group received their first 
information about the stoma at admission the day before surgery. Postoperatively, 
patients in the ERAS group received daily education from a stoma nurse specialist, 
while the patients in the standard group were educated from colorectal ward nurses. 
3.3 Paper III: ERAS care in elderly patients 
This is also a sub-study from the above described RCT, where we focused only on 
patients in the intervention arm (ERAS group). Patients in the ERAS group were 
divided into 3 subgroups depending on age; ≤65 years (n=79), 66–79 years (n=56), 
and ≥80 years (n=19), and we investigated the influence of age on the ERAS 
program. We wanted to evaluate the adherence to an ERAS program in elderly 
patients compared to younger patient, and examine whether the elderly patients had 
the same outcomes as the younger ones. 
3.4 Paper IV: Counselling as an independent strategy to 
reduce hospital stay 
Based on our first RCT (paper I), the perioperative information and guidance to 
patients appear to be quite essential in order to achieve early discharge. This study 
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strongly suggests that trustworthy perioperative information with regard to each 
patient’s expectations, and a continuously guidance in the ERAS elements is an 
important single factor for reducing THS. Further studies would still be necessary to 
understand the specific role and impact of patient-counselling in an ERAS program. 
We therefore enrolled our patients with colorectal resections into a new randomized 
trial in which both arms of the study included the same ERAS elements; the arms 
only differed in terms of perioperative counselling and guidance. Patients were 
randomized to ERAS with standard counselling or ERAS plus extended counselling. 
The patients in the study intervention arm with extended counselling had one or two 
additional outpatient clinic consultations with a dedicated ERAS nurse before 
surgery, whereas patients in the standard counselling group had the ordinary 
preoperative information the day before surgery, where they also were introduced to 
the ERAS criteria. Patients in the intervention and control arm of the study were 
admitted to two separate wards. In the extended counselling group the same nurse 
who gave the preoperative information, also monitored the postoperative course.  
3.5 Statistical analysis 
Paper I-III: A power analysis was carried out after first conducting a pilot study with 
20 patients. In the pilot study the difference in the primary outcome THS was 2.5 
days. In order to detect a difference in length of stay of 2.5 days, in a two-sided 
hypothesis test with a significance level of 5% and a statistical power of 0.8, we 
needed a total sample size of 300 randomized patients divided into an intervention 
and a control arm in both RCTs. 
We used IBM SPSS, version 22 and 23 for statistical analyses, and descriptive 
statistical methods were used to characterize the sample. In all papers, data are 
presented as median and range, and we used chi-squared test to compare discrete 
variables, independent-sample t-test for continuous, normally distributed variables, 
and Mann–Whitney U test for continuous, non-normally distributed variables. 
Continuous outcomes in paper III were analysed with ANOVA or regression analysis. 
The reported p values are based on two-sided tests. 
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Paper II: To detect changes in the 15D score from baseline to 10 days and 30 days in 
both treatment groups, a paired sample t-test was applied, and to compare differences 
between the groups in the change in the 15D score from baseline to 30 days an 
ANOVA regression was used. 
Paper IV: Also in this trial the total sample size was 300 patients, but we planned in 
advance an interim analysis when more than half of the necessary patients were 
included. After we had included and followed-up 164 patients we carried out the 
interim analysis with the statistical program R 3.3 and group sequential design with 
gsDesign 3.0. With a p-value <0.001 for the difference in primary outcome (THS) 
between the extended and standard counselling group, the criterion for ending the 
study was fulfilled. 
 
3.6 Ethics 
All patients received oral and written information about the study according to the 
Helsinki Declaration before they signed a consent form for participation. The study 
was approved by the Regional Committee for Medical and Health Research Ethics of 
Western Norway (reference number 2010/2079) and was registered with Clinical 
Trials.gov (number NCT01610726).  
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4. Results and summary of papers 
4.1 Paper I: 
During a time period of three years 324 patients were randomized and after some 
exclusions, 154 in the ERAS care group and 153 in the standard care group were 




Figure 2 Consort diagram for the trial [217]. 
 
Patients randomized to ERAS care had a significantly shorter THS than in standard 
care (median 5 [range 2-50] vs. median 8 [range 2-48]; p=0.001). There were no 
differences in postoperative C - reactive protein (CRP) levels (which reflects the 
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inflammatory response) or toleration of enteral nutrition postoperatively. There were 
also no differences regarding overall, major, or minor morbidity; reoperation rate; 
readmission rate; and 30-day mortality. 
Patients operated with laparoscopic surgery in both treatment groups had a 
significantly shorter THS than patients operated with open surgery (median 5 vs. 7 
days; p<0.005). 
4.2 Paper II: 
In patients receiving a planned stoma (n=122), the patients randomized to ERAS care 
and peri-operative stoma education had a significantly shorter THS than patients in 
the standard care group (median [range], 6 days [2- 21 days] vs. 9 days [5-45 days]; 
p<0.001). Stoma related complications were common in both treatment groups, 38% 
in the ERAS group with stoma education and 51% in the standard group, but without 
significant differences. There was, however, significantly more complications with 
ileostomies compared to colostomies in both groups (p<0.001).  
 
Health-related quality of life (HRQoL) 
There were no differences in the 15D score or in any dimension level value at 
baseline, 10 days, or 30 days. From baseline to 10 days postoperatively there was a 
significantly and clinically important worsening in the 15D score (ERAS: -0.0868, 
p<0.001; standard care: -0.0910, p<0.001) and from 10 days to 30 days a significant 
and important improvement in the 15D score (ERAS: 0.0273, p=0.001; standard care: 
0.0322, p=0.004). We found no significant differences between the two treatment 




4.3 Paper III 
In this sub-study we analysed the interventional ERAS arm with regard to age of the 
patients. Figure 3 shows a flow chart of patients included in the analysis.  
Figure 3 Flow chart of patients considered for inclusion [219]. 
 
Between the different age groups there were neither significant differences in THS 
(≤65 years, median 5 [range 2–47] days; 66–79 years, median 5.5 [range 2–36] days; 
≥80 years, median 7 [range 3–50] days; p=0.53), nor among all secondary outcomes. 
There were no differences in postoperative tolerance of enteral nutrition in the 
different age group and the adherence to the different ERAS elements was just as 
good in the two oldest age groups as in the younger patients. 
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4.4 Paper IV 
In the time period from 10th March 2015 to 5th December 2016, 179 patients were 
randomised to ERAS plus extended counselling or ERAS with standard counselling. 
We calculated that we needed at least 152 patients in the interim analysis. After 15 
exclusions, we had 164 patients for the final analysis (figure 4) 
 
 
Figure 4 Consort diagram of the trial 
 
A significantly shorter THS was found among patients randomized to ERAS plus 
extended counselling compared to ERAS with standard counselling (median 5 [range 
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2–29] days vs. 7 [range 2–39] days, p<0.001). The adherence to the postoperative 
ERAS elements mobilisation and total oral intake differed between the two treatment 
groups. There were no differences in major or minor morbidity, reoperations, 
readmissions and 30-day mortality between the treatment groups. 
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5. General discussion  
The major finding in this thesis is that ERAS reduces THS, both in younger and older 
patients, as well as in patients receiving a planned stoma. There were no differences 
in major or minor morbidity. The reduced THS is mainly due to extended pre- and 
postoperative patient information, education and guidance. We have shown a 
significantly shorter THS in patients treated with ERAS care plus extended 
counselling, which enables patients to comply especially with postoperative ERAS 
elements, compared to ERAS care with standard counselling after elective colorectal 
surgery.  
5.1 ERAS care vs standard traditional care  
This study showed a significant reduction in THS in the ERAS care compared to 
standard care, although there were no differences in postoperative mortality, 
reoperation, major or minor morbidity or readmission. In order to achieve early 
discharge, perioperative information, guidance and instructions to patients appear to 
be very important. Counselling and continuous repetition of details by trained nurses 
throughout the care pathway help patients to comply with the ERAS program and 
seem to be essential.  
The ERAS approach combines multimodal interventions, rather than one specific 
strategy. Randomized controlled trials comparing ERAS care to standard care have 
demonstrated a significant reduction in hospital stay associated with ERAS pathways. 
However, the results of these studies did not enable us to conclude that one ERAS 
item is more effective than other interventions. The designs of all these studies were 
appropriate for evaluating the overall effect of ERAS interventions, but not various 
single interventions. Consequently, we could not expect that a multivariable model 
comparing the effects of single interventions would uncover meaningful and 
interpretable results. In a large prospective observational study, an association 
between increased protocol adherence and improved outcome was found [213]. There 
is, however, no clear evidence of whether all the elements are equally important and 
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whether all the elements must be conducted entirely strict in order to achieve a good 
result. It is also reasonable that patients who have better outcomes also have a higher 
compliance. Patients who receive a surgical complication will naturally not be able to 
carry out postoperative ERAS elements. It has also been suggested that it is likely 
that compliance with postoperative ERAS elements is of particular importance for 
accelerated postoperative recovery and good progress [220, 221]. A large systematic 
review and meta-analysis could however not show that programs with many ERAS 
elements were more successful than others with fewer components [222].  
The assessment of ERAS vs. standard care is not new, but assessing the specific role 
of preoperative counselling and optimisation in a trial has not been investigated in 
particular. From the data in paper I it was however not possible to assert that 
counselling was more effective than other ERAS elements, such as fluid management 
or laxative use. Upon completion of the first study, we planned a new RCT where we 
wanted to generate more information and insights into the impact of perioperative 
counselling when both study arms were otherwise equal in terms of ERAS criteria 
(paper IV). From previously published literature, it is not possible to find RCT`s that 
focus specifically on patient information and guidance in colorectal surgery. 
Laparoscopic surgery was associated with a significant reduction in LOHS in both 
treatment groups in paper I, although this may be due to selection bias since the 
surgical procedure was not a part of the study protocol. In RCT`s minimal invasive 
surgery has shown to reduce LOHS, but not complication rates [170, 223].  When 
minimal invasive surgery is combined with ERAS, postoperative morbidity is also 
reduced. Laparoscopy rather than ERAS seems, however, to be the reason for this 
reduction in morbidity, and offers independent advantages beyond ERAS [224].  
 
5.2 Stoma education within an ERAS program 
Patients, who were receiving a planned stoma and treated within an ERAS pathway 
with stoma education, had a significantly shorter THS than patients receiving 
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standard care after colorectal surgery. There were no differences between the two 
treatment groups in regard to secondary outcomes. 
In patients receiving a planned stoma little research has been published that compares 
the relationship between stoma education and LOHS. In a recently published review 
article only five studies were found investigating the relationship between stoma 
training and LOHS. Two of the studies found a reduction, while three showed no 
difference [56]. In our opinion the main benefit of pre-operative stoma education is 
that these patients are more capable to start stoma training directly after surgery. 
During the pre-operative education, they have already received stoma training and are 
familiar with the stoma equipment. Comparing patients with and without stoma in the 
ERAS and standard care groups in the main study population (n = 308), the 
difference in THS was greater for those who received a stoma (median [range], 6 
days [2- 21 days] vs. 9 days [5-45 days]; p<0.001) than for those who did not receive 
a stoma (5 days [2-50 days] vs. 6 days [2-48 days]; p=0.35). The difference in 
hospital stay reduction in stoma vs non stoma patients indicates that intensified stoma 
education is the main variable for this reduction, but it might also be that the ERAS 
protocol is more powerful in patients with a stoma. 
Stoma related complications are frequent, but there are few available data in the 
literature. Peristomal dermatitis has been reported in 5-25% of patients with 
ileostomies, and significant fluid loss with dehydration in up to 20% [225]. In our 
study, all complications were registered prospectively and we found a large 
proportion of patients with stoma-related complications. There were fewer stoma-
related complications in the ERAS group but the difference was not significant. As 
stoma-related complications were not the main focus in this trial, it might not have 
the sufficient power regarding this question, even though we had a large number of 
patients. 
Significantly more complications were observed in ileostomies than colostomies. 
Peristomal dermatitis requiring treatment was observed in half of the patients with 
ileostomies, and 18% had high output with large fluid loss and dehydration which 
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resulted in decreased renal function and S-creatinine > 100 μmol/L. High output 
ileostomy in patients who recently have formed a ileostomy was a major problem and 
resulted in readmissions. Severe short-term complications in colostomies were rare. 
5.3 ERAS care in elderly patients 
Although THS was two days longer in the age group ≥80 years compared to the 
youngest age group, there were no significant differences in THS between the three 
different age groups. It was not possible to identify factors that caused the two days 
delayed discharge. Logistical challenges, such as the patient’s own wishes, home care 
situation where elderly patients often live alone, and a situation where elderly often 
have to wait for nursing home placement, are likely causes.  This has also been seen 
in other studies in which elderly patients are discharged 3-5 days after they met the 
discharge criteria [226]. We did, however, not measure days until readiness for 
discharge in our study. 
Postoperative ERAS items are a reflection of the postoperative recovery. If a patient 
is feeling well, compared to a patient with nausea and vomiting, it is more likely that 
the patient will comply with the postoperative ERAS items. These items are markers 
of both protocol compliance and recovery and have been suggested to be of special 
importance for progress and accelerated recovery [220, 221]. Enforced mobilisation 
is a key factor in an ERAS protocol. In one study age >80 years and higher ASA 
score were identified as predictors of delayed mobilisation [58]. In our sub-study, the 
compliance to the different ERAS elements was equally good in the oldest age group 
as in the younger age groups, without particular difference in the level of 
mobilisation. A reason for this may be too strict inclusion among the very oldest 
patients, as some elderly patients were excluded if they could not implement the 
entire ERAS program. We think that especially elderly patients should carry out such 
a program with guidance and supervision of dedicated nurses, particularly in 
important postoperative elements. High risk- and elderly patients are probably those 
who would benefit most from ERAS care with augmented recovery.  
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5.4 Counselling as an independent strategy to reduce 
hospital stay 
This RCT (paper IV) demonstrated a significantly shorter THS in ERAS care plus 
extended counselling compared to ERAS care with standard counselling in patients 
receiving elective colorectal surgery. From the results in paper I we could not 
conclude whether one specific ERAS strategy or the ERAS package as a whole were 
responsible for the beneficial effects, but the results from paper IV suggest that 
extended counselling alone reduces THS significantly. As far as we know this is the 
first randomized study which demonstrates that LOHS in patients undergoing 
colorectal resection in an ERAS setting can be decreased significantly by focusing 
especially on counselling.  
In order to achieve early discharge, it appears to be essential that a dedicated nurse 
provides both the preoperative information and the postoperative supervision. 
Accurate pre- and postoperative information about the patients’ expectations and 
continuous guidance and counselling were important elements for reduced THS. 
Detailed information preoperatively, as well as repetition and continuous counselling 
throughout the care pathway by dedicated nurses, is crucial to motivate patients to 
comply with the ERAS program. The results from this study show that counselled 
patients more strongly comply, especially with postoperative ERAS elements, which 
we think have an important impact on both postoperative recovery and LOHS. 
Good leadership in the hospital and local champions (nurses, surgeons, 
anaesthesiologists) are important factors for a successful implementation of an ERAS 
program [227]. In our case the local champion was a dedicated nurse who followed 
up and supervised all the patients. Even though we cannot show reduced morbidity, 
this supervision and continuous guidance caused a significantly reduction in hospital 
stay. Early discharge from hospital should not be the goal itself, but rather the 
avoidance of particularly major complications. Patients are equally satisfied if they 
are discharged after 3 or 7 days. What matters to patients, is that they feel a safe 
treatment course and avoid complications.  Nevertheless, LOHS has huge financial 
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consequences as one hospital day at the regular ward costs around 10000, - NOK.  
Good preoperative patient information and education, as well as continues follow up 
by a dedicated person, as in our case a dedicated nurse, can reduce hospital costs 
significantly. 
5.5 Strengths, limitations and methodological 
considerations 
The main strengths of the studies (paper I and IV) are the randomized controlled 
trial design. Besides that, we had two separated wards for patients allocated to the 
intervention and control arms of the studies. These wards had different nursing staff 
to reduce the possibility of introducing confounders. During the entire study period 
the department had a stable staff of seven senior surgeons in a separate colorectal 
unit. To minimize observer-related bias, all postoperative controls were carried out by 
one nurse and two surgeons. A high proportion of eligible patients were included in 
the studies.  In the first RCT we included more than 300 patients over a 3-year period, 
and in the second RCT more than 150 patients were included in 1.5-year period.  All 
data were registered prospectively by one nurse and one surgeon. 
All studies have several limitations. The main limitation of both RCTs was the 
absence of blinding. Neither patients nor staffs were blinded with regard to treatment 
groups. In both RCTs the two treatment groups were admitted to different wards and 
a blinding would not be possible. At least the staff at the two wards could not have 
been blinded, but one could argue that the patients may have been blinded, although it 
would have been difficult. An externally audit system as the “ERAS Interactive Audit 
System”, was not performed.  This is an on-line interactive software tool for 
implementation and monitoring compliance to the protocol, developed by the “ERAS 
Society”. Another limitation in paper I is the difficulty to define standard care. Some 
ERAS items are also implemented in modern standard care, and were therefore also 
implemented in the standard conventional group. This relates not only to the medical 
care provided, but also to the nursing and allied professional care provided (e.g. early 
enteral challenge, mobilization etc.).  ERAS strategies, which are nowadays 
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considered as 'standard of care', may have affected the standard care group and made 
it more difficult to identify differences.  
The rate of laparoscopic procedures was higher in the included cohort. It is well 
described that laparoscopic surgery plays an important role reducing surgical stress 
and postoperative length of stay. Some authors, supported by the LAFA trial, 
proposed that laparoscopy is an important item of ERAS protocols [7].  The lower 
rate of laparoscopic resection in the excluded cohort could be a selection bias.  
One can also argue that one should not include both rectal- and colon surgery in the 
same RCT with the argument that these are very different operations and that it’s hard 
to “ERAS/Fast-track” rectal cases. We have, however, included both rectum and 
colon resections in this study as we think it should be possible to use ERAS 
independently of the type of colorectal procedure. When the current study was 
designed, we perceived the literature and practical approach to ERAS as not being 
different with regard to colon and rectal resections, and thus, chose to include patients 
undergoing all types of colorectal resections. 
The main limitation in paper II is, that the relative benefit of giving information and 
counselling to patients planned to have a stoma is difficult to isolate from other 
benefits of an ERAS pathway programme, including global information and 
counselling to all patients in this group. The main conclusion from this study is 
regarding the overall benefit of ERAS pathway on this specific population. The 
isolated effect of intensified stoma education may not be properly evaluated within 
the present design. One could argue that the methodology of this trial cannot answer 
the question about the benefit of information and counselling correctly. Two 
interventions - stoma education and ERAS were mixed and analysed as one 
intervention. To answer the question, patients randomised to ERAS or standard care 
should have been stratified further in stoma education vs. non education. 
In the sub-study analysis in paper III the proportion of included patients in the oldest 
age group was smaller than in the younger age groups, which could be a selection 
bias where only the fittest patients in the oldest age group were included. There is a 
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great heterogeneity regarding comorbidities in elderly patients. What treatment older 
patients should be offered, should to a lesser extent, be based on chronological age 
and more on biological characteristics. A frailty evaluation or risk stratification with a 
tool like “Comprehensive Geriatric Assessment” has been recognized as a better test 
in elderly patients than the more traditional comorbidity scores [64, 65]. Such a 
stratification of frailty was not applied in our study. 
Whether the design of the present study is adequate to find any differences between 
age groups is debatable. The initial sample size was not calculated to find difference 
in terms of outcome between elderly and younger within one arm. Therefore, the 
reason for why no difference was found may have been due to quite low number of 
patients, especially in the group aged more than 80 years (n=19). Based on these data 
it can be concluded, that there was no difference between elderly and younger 
patients. 
A potential limitation in paper IV is that ERAS care took place for a longer period of 
time in the extended counselling group; it began in 2011 vs. 2015 in the standard 
counselling group. An earlier study that analysed adherence to ERAS items and 
length of hospital stay, revealed higher adherence rates in the first 2 years following 
implementation of ERAS compared to the subsequent 2 years [228]. Thus, the 
disparity in ERAS program commencement could have favoured the standard 
counselling group with better adherence to the protocol by nurses in the standard 
counselling arm since the program was new to that ward.  
Although we see the use of separate wards as strength of the study, it could also be 
argued to be a limitation to the study design. In both groups, nurses experienced in 
colorectal surgery provided the care; in fact, the amount of experience of the nurses 
with colorectal patients was higher in the control group with ERAS and standard 
counselling. More experienced nursing staff in general can identify and "rescue" 
postoperative complications and prevent major morbidity and reduce THS. Major 
complications including anastomotic leak, multi-organ failure or respiratory failure 
requiring ICU admission are less a consequence of lack of extended counselling and 
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more a consequence of the system of care that supports the patients’ postoperative 
recovery.  Although there were more complications in the standard counselling 
group, the difference was not significant. In our first trial (paper I) the results were 
opposite, with more complications in the ERAS- compared to the standard- care 
group, also without statistical significance.  
Though not significant, there was a higher rate of protective ileostomy following low 
anterior resection in the standard counselling group that may contribute to longer 
THS in this group. 
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6. Conclusions and future perspectives 
 
After elective colorectal surgery ERAS care had a significantly shorter THS than 
standard care without any difference in surgical or general complications. 
LOHS in patients with the need for stoma creation was reduced significantly by 
preoperative stoma education and postoperative guidance by dedicated nurses as part 
of an ERAS care pathway. 
Elderly patients benefited from an ERAS program with reduced LOHS and adhered 
to the program similar to their younger counterparts.  
Perioperative information and guidance were associated with a significantly reduction 
in LOHS and seem to be the most important factors for the reduced LOHS in an 




Although ERAS enthusiasts’ believe that a strict implementation of the entire 
program should be carried out, it is currently unknown which ERAS items have the 
greatest benefit for outcome, especially for older patients. Minimal invasive surgery 
is undoubtedly an important factor, but it has to be investigated which of the other 
ERAS items may be superfluous in the era of laparoscopy.  ERAS trails have 
demonstrated reduced LOHS, but no reduction in serious complications or mortality. 
When evaluating ERAS studies LOHS as outcome seems reasonable for younger 
patients, but probably not for older patients. They often remain in hospital even if 
they are ready for discharge. Studies investigating the functional status before and 
after surgery should be performed in elderly patients. In our opinion, in frail patients 
the concept of prehabilitation will improve the functional capacity before surgery, 
and most likely play an important role in the future.  
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The ERAS approach is a dynamic protocol and not set in stone [229]. Further studies 
must be conducted looking at individual ERAS elements. Reducing the risk of 
surgery and morbidity, rather than focusing on LOHS as primary outcome should be 
focused.  A number of areas within the ERAS protocol will most probably in some 
way be changed or at least be individualised in accordance with new evidence.  
From a surgical perspective, the most important issue is to reduce mortality and major 
complications.  Large studies have shown similar complication rates in hospitals, but 
very different rates in postoperative mortality. Timely recognition and management 
of complications seem to be the main reasons [230, 231]. A very important question 
is how this can be improved. Early warning scores (EWS) with single bedside 
parameters have not shown to reduce mortality [232]. There are also currently no 
good accurate biochemical markers that indicate serious complications.  Finding good 
clinical and biochemical markers that map the patients’ recovery and thus also 
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Abstract
Aim The aim of this randomized clinical trial was to
compare patients treated using a multimodal approach
[enhanced recovery after surgery (ERAS)], with a special
focus on counselling, to patients treated in a standard
conventional care pathway, who underwent elective col-
orectal resection.
Method In a single-centre trial, adult patients eligible for
open or laparoscopic colorectal resection were random-
ized to an ERAS programme or standard care. The pri-
mary end-point was postoperative total hospital stay.
Identical discharge criteria were defined for both treat-
ment groups. Secondary end-points included postopera-
tive complications, postoperative C-reactive protein
levels, postoperative hospital stay, readmission rate and
mortality. All parameters were recorded before operation,
on the day of surgery and daily thereafter until discharge.
Results Total hospital stay was significantly shorter
among patients randomized to ERAS than among the
standard group [median 5 days (range 2–50 days) vs
median 8 days (range 2–48 days); P = 0.001]. The two
treatment groups exhibited similar outcomes regarding
overall major and minor morbidity, reoperation rate,
readmission rate and 30-day mortality. There were also
no differences in tolerance of enteral nutrition or in the
inflammatory response, as reflected by postoperative C-
reactive protein levels.
Conclusion ERAS care was associated with a signifi-
cantly shorter length of hospital stay. Without any dif-
ference in surgical or general complications, tolerance of
enteral nutrition or postoperative C-reactive protein
levels, peri-operative information and guidance for
ensuring that patients comply with the ERAS approach
appear to be important factors to reduce the length of
hospital stay.
Keywords Colorectal surgery, ERAS, complication,
counselling
What does this paper add to the literature?
Although the benefits of enhanced recovery after sur-
gery on length of stay are widely recognized, the main
reasons for the reduction in hospital stay are not well
understood. This study suggests that accurate peri-
operative information and continuous guidance are
important for this reduction.
Introduction
Enhanced recovery after surgery (ERAS) is a multi-
modal peri-operative approach that aims to reduce
organ dysfunction and surgical stress response and thus
to reduce postoperative morbidity and length of hospi-
tal stay [1]. Several prospective studies have demon-
strated associations between ERAS and shorter hospital
stay and reduced morbidity, without a difference in
mortality [2–4]. To date, randomized trials have shown
that patients recover faster when traditions are
amended, including changes in analgesia and anaesthetic
procedures, mobilization procedures, better information
Correspondence to: Havard Mjørud Forsmo, MD, Department of
Gastrointestinal and Emergency Surgery, Haukeland University Hospital, 5021
Bergen, Norway.
E-mail: havard.forsmo@helse-bergen.no
Colorectal Disease ª 2016 The Association of Coloproctology of Great Britain and Ireland. 18, 603–611 603
Original article doi:10.1111/codi.13253
to patients and determined effort by the department to
reduce hospital stay. Some randomized trials have
reported no difference in the complication rate [5–10],
while others show a difference in minor complications
[11–14]. A 2011 Cochrane Review, however, stated
that the quantity and especially the quality of published
data are low [15].
An early prospective observational study of 98
patients was conducted from 2000 until 2003 at our
own hospital and Haugesund Hospital, according to
the ERAS principles. This study reported that 80% of
patients were discharged on day 5 with a tendency
toward a lower complication rate [16]. The length of
the postoperative hospital stay varies broadly with geog-
raphy. Most continental countries traditionally have a
longer postoperative hospital stay than the Nordic
countries, and it can also be difficult to generalize find-
ings from Asia to Nordic and Norwegian conditions.
We conducted a controlled, randomized study in which
we compared patients treated by the best possible mul-
timodal approach (ERAS) with a special focus on coun-
selling to patients treated in a standard care pathway.
The main goal of this study was to determine whether
we were able to decrease the total length of hospital
stay, mainly as a result of reduced morbidity.
Method
This prospective randomized clinical trial was under-
taken at the Haukeland University Hospital in Bergen,
Norway. It was registered with ClinicalTrials.gov (num-
ber NCT01610726). Adult patients older than 18 years
scheduled for elective open or laparoscopic colorectal
surgery for malignant or benign diseases, with or with-
out stoma, were eligible for inclusion. Patients with rec-
tal cancer who had had pelvic radiation were also
included. Patients were informed both orally and in
writing 1–3 weeks before surgery, and written consent
was obtained. Patients were excluded if a multivisceral
resection was planned or if the patient was scored
American Society of Anesthesiologists grade IV. Addi-
tional exclusion criteria were pregnancy, emergency
operations, difficulty to give informed consent because
of impaired mental capacity, or inability to adapt to the
ERAS criteria. Randomized patients were excluded if
the intended colonic or rectal surgery was not per-
formed. The regional ethics committee in Western Nor-
way approved the trial (reference number 2010/2079).
Randomization
Patients fulfilling the inclusion criteria and consenting
to participate in the study were randomized to ERAS or
standard care. A randomization list for 324 patients
with an allocation ratio of 1:1 was generated with block
randomization. An independent statistician prepared the
sequence in advance. Allocation assignments were
deposited in consecutively numbered and sealed letters
and stored locked in the study office. Patients were
informed about their treatment group at the time of
information, 1–3 weeks before surgery. Neither the
patient nor the physician was blinded to the treatment
assignment.
Objectives and end-points
The primary end-point was total hospital stay (THS)
measured in days. This was defined as postoperative
hospital stay plus additional days if readmission was nec-
essary within the first 30 days after surgery. Discharge
criteria were defined and were similar for both treat-
ment groups. These included (i) postoperative pain ade-
quately controlled with oral medication (Visual Analog
Scale <4), (ii) mobilized and out of bed more than 6 h
each day, (iii) bowel function (faeces or repeated flatus)
and (iv) no complications requiring treatment in hospi-
tal. All patients with a stoma were comfortable with
stoma care before discharge.
Secondary end-points were postoperative complica-
tions, postoperative C-reactive protein (CRP) levels,
postoperative hospital stay, readmission rate and mortal-
ity. Definitions for complications were established prior
to study commencement and the incidence of complica-
tions was also recorded in accordance with the Clavien–
Dindo classification [17].
All parameters were recorded before operation, on
the day of surgery and daily thereafter until discharge.
All patients had an outpatient control on postoperative
days 10 and 30. An early postoperative control at day
10 was performed to record possible postoperative com-
plications occurring after discharge and to refer the can-
cer patients for adjuvant treatment if indicated. To
minimize observer-related bias, one dedicated nurse and
the same two surgeons carried out all controls.
Peri-operative care and surgical technique
Patients randomized to ERAS had one to two consulta-
tions before surgery with the ERAS nurse. They were
informed about the principles of ERAS care and the
goal of the project. They were told about their own
role in retraining so that they understood the impor-
tance of their own efforts, that they would eat the same
day as the operation, the importance of mobilization
and drinking and that they should preferably do with-
out intravenous fluids. Patients were also informed
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about nutritional drinks, the day of removal of any uri-
nary catheter, drain and epidural analgesia, the expected
length of stay and the discharge criteria. In both
groups, patients operated with colon resection had no
drain, while all patients with rectal resections received a
pelvic drain.
Patients allocated to the ERAS group were treated
according to the ERAS protocol described in the con-
sensus guidelines [18,19]. The ERAS items used in
the study are listed in Table 1. Patients randomized to
standard care were treated according to traditional
peri-operative care. Some ERAS items are also included
in modern standard care that is currently practised in
Norway and therefore were also implemented in that
group.
Patients randomized to ERAS recovery during hospi-
talization were admitted to a separate ward from the
standard group. Nurses who worked with the ERAS
group had special training and education in the princi-
ples of ERAS. All operations were performed by or
under the supervision of a colorectal surgeon. Five sur-
geons performed both laparoscopic and open surgery
and two surgeons performed open surgery only. The
operating surgeon decided which surgical approach
should be selected. Open resections were performed
through a midline incision.
In both groups, patients were allowed to drink clear
liquids up to 2 h before surgery. Bowel preparation was
standard for rectal surgery, while the main surgeon pre-
operatively determined the appropriate bowel prepara-
tion on an individual basis for patients undergoing
colon surgery. Bowel preparation did not include
enema. All patients received thromboembolic prophy-
laxis, preoperative antibiotics and prevention of
hypothermia. All patients in both groups were encour-
aged to mobilize early starting immediately after surgery
and were allowed to start drinking and eating immedi-
ately after surgery if they wanted. In the ERAS group
only, we enforced patient mobilization and oral feeding
postoperatively. In the ERAS group, patients had a car-
bohydrate-loaded drink (ProvideXtra, 200 ml) the
evening before surgery and 2 h before surgery. Routine
preoperative glucocorticoid as part of peri-operative
management was not used.
Thoracic epidural anaesthetic agents were inserted at
Th9-11 with a continuous dose of bupivacaine 1 mg/
ml, fentanyl 0.002 mg/ml and adrenalin 0.002 mg/ml.
Epidural anaesthesia was used only in open surgery, in
both the ERAS and standard care groups. General
anaesthesia in the ERAS patients was total intravenous
anaesthesia with propofol and remifentanil. In the con-
trol group, the general anaesthesia was gas with propo-
fol or thiopental, fentanyl, and isofluran or sevofluran.
Nasogastric tubes were removed immediately after extu-
bation in both groups.
Statistical analysis
THS was the primary outcome measure of the interven-
tion. First, a pilot study with 20 patients was con-
ducted. In this, the median difference in total length of
stay was 2.5 days. Based on a power analysis for a
power of 0.8 and significance level of 0.05, a total sam-
ple size of 300 patients was needed to detect a mini-
mum reduction in THS of 2.5 days between the ERAS
and conventional groups. The 20 patients previously
analysed in the pilot study were not included in the cur-
rent study.
Statistical analysis was performed on an intention-to-
treat basis using IBM SPSS Statistics software, version
22. Descriptive statistical methods were used to charac-
terize the sample. Data are presented as median and
range. We used the chi-squared test to compare discrete
variables. The Mann–Whitney U test was used for con-
tinuous, non-normally distributed variables, and an
independent-sample t test was used for continuous, nor-
mally distributed data.











Antimicrobial prophylaxis U U
Peri-operative
Fluid restriction U
Anaesthetic protocol TIVA Gas
Prevention of hypothermia U U
Epidural anaesthesia U U
Minimal invasive incisions
Postoperative
No routine use of nasogastric tubes U U
No use of drains in colon surgery U U
Enforced postoperative mobilization U
Enforced postoperative feeding U
No systemic morphine use U
Standard laxative U
Early removal of urine catheter U
Total number 16 5
TIVA, total intravenous anaesthesia.
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Results
Between 5 January 2012 and 4 March 2015, 324
patients were randomly assigned to the ERAS pro-
gramme or standard care. Of 653 eligible patients, 329
were not included, mainly for logistical reasons and a
lack of capacity in the ERAS outpatient clinic (Fig. 1).
Patients who underwent surgery in July and August
were not included due to the summer vacation of the
responsible study nurse and surgeons. Among patients
who met the inclusion criteria (n = 298) but were not
included in the study, there were no differences in age
(median 68 years) or the male/female ratio (151/147)
compared with the included patients. There were fewer
laparoscopies in patients not included in the study [81/
298 (29.2%) vs 122/307 (39.7%)] and a smaller pro-
portion of rectal operations [125/298 (41.9%) vs 167/
307 (54.4%)], including proctocolectomy. The patient
characteristics and surgical details for the included
patients are summarized in Table 2. Baseline character-
istics between the two treatment groups did not differ
significantly.
THS was significantly shorter among patients ran-
domized to the ERAS group than the standard group
[median 5 (range 2–50) days vs median 8 (range 2–
48) days (P = 0.001)] (Table 2). All discharge criteria,
such as passage of first flatus, passage of first stool and
pain control with oral medication, were achieved earlier
in the ERAS group. The interval to the toleration of
solid food without nausea did not differ between the
two groups (Table 3). Postoperative CRP levels were
lower on postoperative day 2 in the standard than in
the ERAS group; otherwise there were no differences
between the groups. In both groups (ERAS and stan-
dard), patients operated by laparoscopic surgery exhib-
ited a significantly shorter THS than patients operated
openly (median 5 vs 7 days; P < 0.005).
The two treatment groups exhibited similar out-
comes regarding overall, major and minor morbidity,
reoperation rate, readmission rate and 30-day mortality
(Tables 4 and 5). Complications did not differ signifi-
cantly between the groups (Clavian–Dindo ≥3b).
Adherence to ERAS and standard care protocols is
summarized in Table 6. Although there were no differ-
ences in intra-operative fluid load, significantly less
intravenous water was administered to the ERAS group
than the standard care group during the first 24 postop-
erative hours and the first seven postoperative days
Assessed for eligibility n = 653
Randomized
n = 324
Excluded n = 329
Did not meet inclusion criteria n = 31
Refused to participate n = 25
Logistical and lack of
resources n = 273
(see text)
Allocated to ERAS care n = 162 Allocated to standard care n = 162
Excluded n = 8
Protocol violation (intended surgery not
performed) n = 6
Emergency operation n = 1
Operated in another hospital n = 1
Excluded n = 9
Protocol violation (intended surgery not
performed) n = 6
Emergency operation n = 1
Operated in another hospital n = 2
Analyzed n = 154
Excluded from analysis n = 0
Analyzed n = 153






















Figure 1 CONSORT diagram for the trial.
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(P = 0.001). Ninety-one patients in both groups
received thoracic epidural analgesia, but significantly
more patients in the ERAS group experienced removal
of the epidural catheter on day 2 (P < 0.001). Signifi-
cant differences were also observed in a large number of
other ERAS elements, such as type of anaesthesia,
intake of carbohydrate drinks, use of laxatives and oral
opiates, total oral intake after surgery, postoperative
mobilization and early removal of the urinary catheter.
Discussion
The study demonstrated a significantly shorter THS in
patients treated with ERAS care compared with stan-
dard care after colorectal surgery. Earlier discharge from
hospital alone should not, however, be the primary
object of surgical care. The main focus should be to
improve care by decreasing morbidity. This study
revealed no differences between the two treatment
groups regarding mortality, major or minor morbidity,
reoperations or readmissions.
The trial was initiated to compare an ERAS pro-
gramme with standard peri-operative care in an everyday
practice of open and laparoscopic colorectal surgery.
Previously published cohort studies and randomized
controlled trials have shown that the ERAS imparts
benefits regarding hospital stay and bowel function.
While a few randomized trials have indicated less mor-
bidity [11–14], others have indicated no difference [5–
10]. Most of these studies have included few patients or
have included patients over a long time period, without
reporting the total number of eligible patients who were
assessed. In our study, there were relatively many com-
plications. We have prospectively registered complica-
tions very carefully, and the largest proportion included
minor complications.
The main strengths of our study, besides the ran-
domized controlled trial design, are the high proportion
of eligible patients included in the study and the use of
Table 2 Patient characteristics and surgical details.






65 (23–89) 66 (19–93) 0.810*
Male/female ratio 83/71 82/71 0.960†



























Laparoscopy 62 60 0.849†
Open surgery 92 93




168 (76–432) 161 (46–393) 0.420‡
Blood loss, median
(range), ml
150 (0–1500) 150 (0–1700) 0.196‡










(n = 153) P
Total hospital stay,
median (range), days




5 (2–50) 7 (2–48) <0.001*
Days to fulfil discharge
criteria, median (range)
Passage of first flatus 1 (0–4) 1 (1–14) <0.001*




2 (0–9) 1 (0–12) 0.612*
Pain control with
oral medication
2 (0–9) 4 (0–16) <0.001*
CRP levels, median
(range), mg/l
Preoperative 2 (1–42) 2 (1–152) 0.926*
Day 2 postoperative 121 (19–499) 96 (7–454) 0.008*
Day 10 postoperative 10 (1–216) 12 (1–298) 0.921*
Day 30 postoperative 3 (1–119) 4 (1–257) 0.178*
CRP, C-reactive protein.
*Mann–Whitney U test.
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two completely separate wards for patients allocated to
the different study arms. These wards were staffed by
different nurses to minimize the possibility of introduc-
ing confounders into treatment effects. The nurses in
the ERAS department had received special training in
the principles of ERAS and all patients were monitored
daily by a dedicated nurse. In addition, the department
had a separate colorectal unit with a stable staff of seven
senior surgeons during the entire study period. To min-
imize observer-related bias, all checks at days 10 and 30
were conducted by the same dedicated nurse and the
same two surgeons. All prospective data registration was
performed by one nurse and one surgeon. We included
more than 300 patients over a 3-year period. Main
causes of not including patients were logistical reasons.
Due to a lack of capacity in the ERAS outpatient clinic,
the staff secretary arbitrarily bypassed patients into the
non-ERAS outpatient clinics, and during the summer
vacation no patients were included in the study. Com-
pared with patients not included in the study, more
included patients underwent a laparoscopic procedure
and a higher proportion underwent rectal resection.
Although these differences may reflect a selection bias,
patient randomization and inclusion was a continuous
process, except during the summer vacation. Both colon
and rectum resections have been included in this con-
trolled randomized study as in our opinion it should be
possible to apply ERAS criteria to surgical patients in a
randomized controlled study design independent of the
type of surgical procedure.
Table 4 Surgical and non-surgical complications.
ERAS care (n = 154) Standard care (n = 153) P*
Overall morbidity < 30 days, n (%) 65 (42.2) 68 (44.4) 0.693
Patients with one or more major complications, n (%) 17 (11.1) 12 (7.8) 0.329
Total major complications, n (%)
Anastomotic leakage/patients with an anastomosis 10/117 (8.5) 4/122 (3.3) 0.084
Colon 3/59 (5.1) 2/77 (2.6) 0.447
Rectum 7/58 (12.1) 2/45 (4.4) 0.174
Abdominal wall dehiscence 5 (3.2) 5 (3.3) 0.992
Mechanical ileus requiring reoperation 0 (0) 1 (0.7) 0.315
Other complications requiring reoperation† 2 (1.3) 2 (1.3) 0.995
Respiratory complications requiring ICU 2 (1.3) 0 (0) 0.156
Other major complication‡ 4 (2.6) 1 (0.7) 0.178
Patient with one or more minor complications, n (%) 53 (34.4) 63 (41.2) 0.257
Wound infection, abdominal 10 (6.5) 13 (8.5) 0.505
Wound infection, perineal 8 (25.0) 9 (32.1) 0.803
Intra-abdominal infection, antibiotic treated or drainage 11 (7.1) 6 (3.9) 0.217
Prolonged postoperative ileus 4 (2.6) 7 (4.6) 0.351
Pneumonia 7 (4.5) 8 (5.2) 0.791
Pleural effusion requiring drainage 5 (3.2) 3 (2.0) 0.474
Pulmonary embolism (PE) 2 (1.3) 0 (0) 0.156
Cardiac arrhythmia 2 (1.3) 3 (2.0) 0.652
Urinary infection 11 (7.1) 16 (10.4) 0.305
Urine retention 9 (5.8) 15 (9.8) 0.202
Gastrointestinal bleeding not requiring intervention 1 (0.6) 1 (0.6) 0.995
Renal failure (S-Creatinine > 100 lmol/l) 8 (5.2) 7 (4.8) 0.791
Hyponatremia (S-Sodium < 130 mmol/l) 1 (0.06) 3 (2.0) 0.314
Postoperative confusion 3 (1.9) 3 (1.9) 0.994
Other minor complication§ 8 (5.2) 4 (2.6) 0.243
Reoperations, n (%) 17 (11.0) 11 (7.2) 0.241
Readmission < 30 days, n (%) 29 (18.8) 21 (13.4) 0.226
Mortality < 30 days, n (%) 3 (1.9) 0 (0) 0.084
*v²-test.
†Other complications requiring reoperation: postoperative bleeding, deep abdominal infection, iatrogenic bowel perforation.
‡Other major complication: Cerebral vascular accident, gastrointestinal bleeding requiring endoscopic intervention, sepsis.
§Other minor complication: paraesthesia of arm after laparoscopy, port site bleeding, pleuritis, subcutaneous infections, antibiotic
treated infection unknown cause, transient ischemic attack with normal MRI.
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As with many other trials, the main limitation of this
study is that it has become increasingly difficult to define
standard care. Some ERAS strategies are considered the
current ‘standard of care’, while the omission of elements
of those strategies, such as antimicrobial prophylaxis,
prevention of hypothermia and thoracic epidural anaes-
thesia during open surgery, may be considered unethical.
This may have affected the results from the standard
group and made it more difficult to identify significant
differences. As the experience of staff surgeons, nurses
and paramedical staff with ERAS recovery has increased,
it has not been possible to exclude all ERAS items to
obtain a true traditional care pathway as a control group,





care (n = 153) P*
Grade I 26 31
Grade II 18 18
Grade IIIa 3 7
Grade IIIb 15 10 ≥ Grade IIIb 0.088
Grade IVa 1 1
Grade IVb 0 0
Grade V 3 0
*v² test.
Table 6 Adherence to the study protocol.
ERAS care (n = 154) Standard care (n = 153) P
Preoperative phase – yes, n (%)
Extended preoperative counselling 154 (100) 2 (1) <0.001*
Omission of bowel preparation 38 (25) 39 (25) 0.21*
Intake of CHL evening before surgery, median (range), ml 200 (20–200) 0 (0–0) <0.001‡
Day of surgery – yes, n (%)
No preoperative fasting 154 (100) 153 (100) 1*
Intake of CHL 2 h before surgery, median (range), ml 200 (20–200) 0 (0–0) <0.001*
No premedication 103 (67) 92 (60) 0.258*
Laxative (lactulose 10 ml) 154 (100) 0 (0–0) <0.001*
Antimicrobial prophylaxis (doxycycline, metronidazole) 154 (100) 153 (100) 1*
Thoracic epidural analgesia 91 (59) 90 (59) 0.962*
Type of anaesthesia – gas/TIVA, n 1/153 151/2 <0.001*
Prevention of hypothermia 154 (100) 153 (100) 1*
Intra-operative fluid loading, median (range), l 2.8 (0.9–5.7) 2.6 (1.4–6.5) 0.282†
Total oral intake after surgery, median (range), l 0.6 (0–3.0) 0.2 (0–1.4) <0.001†
Mobilization 24 h after surgery, median (range), min 180 (0–420) 5 (0–300) <0.001‡
Intravenous fluid, median (range), l
First 24 h, included intra-operative 3.9 (1.9–9.9) 4.4 (1.8–9.5) 0.001†
First 7 days, included intra-operative 5.6 (1.9–19.2) 7.8 (2.8–30.1) <0.001†
Total oral intake, median (range), l
POD 1 1.6 (0.3–3.2) 1.0 (0.1–2.5) <0.001†
POD 2 1.6 (0.5–3.5) 1.3 (0.1–2.5) <0.001†
Start laxative POD 1 – yes, n (%) 123 (80) 5 (3) <0.001*
Use of oral opiates – yes, n (%) 63 (40) 83 (54) 0.02*
Nasogastric tube postoperatively – yes, n (%) 5 (3) 18 (12) 0.004*
Removal of urine catheter, median (range), days 2 (1–21) 4 (1–28) <0.001*
Removal of thoracic epidural analgesia, median (range), days 2 (0–5) 4 (0–6) <0.001†
Mobilization, median (range), min
POD 2 240 (15–540) 65 (0–630) <0.001‡
POD 3 250 (30–660) 140 (10–720) <0.001‡
CHL, carbohydrate-loaded drink (ProvideXtra); gas, gas anaesthesia with isoflurane or sevoflurane; TIVA, total intravenous anaes-
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but in our study significant differences were observed for
a large number of ERAS elements. Another limitation of
our study was the absence of blinding of the treatment.
Neither the patient nor the physician or nurses were
blinded to the treatment assignment. As patients were
admitted to two separate wards it would not be possible
to blind patients or staff.
A widely accepted intention of ERAS is to enhance
patient recovery by more quickly restoring normal physi-
ological function and attenuating the surgical stress
response. The length of time required to regain bowel
function was shorter in patients who received the ERAS
protocol, although this is difficult to objectify. It is likely
that bowel function is better assessed by the tolerance of
enteral challenge than by excretory function. The dis-
charge criteria of passage of first flatus, passage of first
stool and adequate pain control with oral medication
were all achieved earlier in the ERAS group. What we
regard as the most important criterion, however, the abil-
ity to tolerate solid food without nausea, did not differ
between the two groups (Table 2). Moreover, there was
no difference in postoperative CRP levels between
groups, indicating the lack of differential inflammatory
response, and on the second postoperative day CRP levels
were lower in the standard than in the ERAS group.
An important factor is the increasing use of minimal
invasive colorectal surgery. Large randomized controlled
trials comparing open and laparoscopic colon surgery
demonstrated significantly reduced length of hospital
stay for laparoscopic procedures [20,21]. The total
length of hospital stay was significantly shorter in
laparoscopically operated patients. As the surgical
approach was not part of the trial protocol, we cannot
exclude the possibility of selection bias, but the number
of patients who underwent laparoscopic surgery did not
differ between study arms, suggesting that selection bias
is unlikely to have influenced the results.
Like many of the other randomized controlled trails
[5–10], the present study revealed no differences in
mortality, major or minor morbidity, reoperation or
readmission, which may explain the shorter THS in the
ERAS group. There were also no between-group differ-
ences in bowel function in the tolerance of enteral
nutrition or surgical stress (according to postoperative
CRP levels). In most studies the length of stay is the
primary outcome, but the reasons for delay in discharge
are mostly not given. Even with established discharge
criteria, not all patients are discharged in everyday prac-
tice when they meet the criteria. This may be due to
logistical difficulty or the patient’s own wishes. The
peri-operative information and instructions to patients
are essential to achieve early discharge, but this is not a
goal in itself. Patients are equally satisfied if they are dis-
charged after 5 or 7 days [10]. What matters for the
patient is the experience of a safe treatment course with
a minimum of complications. It has been shown that
the more ERAS items are implemented, the more the
postoperative course is improved [22], but the evidence
is far from clear whether all elements are equally impor-
tant. The results of this study do not allow the conclu-
sion that one ERAS item is more effective than another.
The ERAS approach consisted of a package of interven-
tions that were implemented differently between groups
but equally within each group. Thus, the groups had
very little or no variation with respect to single inter-
ventions. This design is appropriate for evaluating the
entire package of interventions, but not for comparing
interventions. Consequently, it cannot be expected that
a multivariate model comparing the effects of single
interventions will lead to meaningful and interpretable
results. Given the similar morbidity, postoperative CRP
levels and the tolerance of enteral nutrition in both
groups, the present study suggests that accurate peri-
operative information about each patient’s expectations
and continuous guidance for ERAS elements is a highly
important factor for reduced THS. Continuous coun-
selling and repetition of details by trained personnel
throughout the care pathway seem to be important for
motivating the patient to comply with their ERAS pro-
gramme and it is our clear impression that counselled
patients more strongly comply with the ERAS criteria.
We believe that patient commitment to the programme
has an important impact on recovery and the time to
discharge from the hospital.
Further studies will be necessary to assess the impact
of counselling when groups of patients are otherwise
equal in terms of ERAS criteria. We are therefore enrol-
ling our colorectal patients into a new randomized
study in which both study arms contain the same ERAS
items and only differ in peri-operative information and
follow-up by dedicated nurses.
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 Patients with stoma formation in colorectal surgery benefits from an ERAS programme.
 Hospital stay can be reduced significantly by stoma education and counselling.
 Stoma formation is associated with high frequency of stoma related complications.
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a b s t r a c t
Introduction: Stoma formation delays discharge after colorectal surgery. Stoma education is widely
recommended, but little data are available regarding whether educational interventions are effective.
The aim of this prospective study was to investigate whether an enhanced recovery after surgery (ERAS)
programme with dedicated ERAS and stoma nurse specialists focusing on counselling and stoma edu-
cation can reduce the length of hospital stay, re-admission, and stoma-related complications and
improve health-related quality of life (HRQoL) compared to current stoma education in a traditional
standard care pathway.
Methods: In a single-center study 122 adult patients eligible for laparoscopic or open colorectal resection
who received a planned stoma were treated in either the ERAS program with extended stoma education
(n ¼ 61) or standard care with current stoma education (n ¼ 61). The primary endpoint was total
postoperative hospital stay. Secondary endpoints were postoperative hospital stay, major or minor
morbidity, early stoma-related complications, health-related quality of life, re-admission rate, and
mortality. HRQoL was measured by the generic 15D instrument.
Results: Total hospital stay was significantly shorter in the ERAS group with education than the standard
care group (median [range], 6 days [2e21 days] vs. 9 days [5e45 days]; p < 0.001). Regarding overall
major and minor morbidity, re-admission rate, HRQoL, stoma-related complications and 30-day mor-
tality, the two treatment groups exhibited similar outcomes.
Conclusion: Patients receiving a planned stoma can be included in an ERAS program. Pre-operative and
postoperative stoma education in an enhanced recovery programme is associated with a significantly
shorter hospital stay without any difference in re-admission rate or early stoma-related complications.
© 2016 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.
1. Introduction
Stoma formation is a well-known cause of delayed discharge
after colorectal surgery [1e3]. Although education is widely rec-
ommended for patients receiving a new stoma, few data are
available on the effect of educational interventions on decreased
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length of stay, re-admissions, and stoma complications. A recently
published systematic review of educational interventions for stoma
patients concluded that no consensus exists on the benefit of stoma
education, though the grade of evidence was low [4]. Enhanced
recovery after surgery (ERAS) is a multimodal peri-operative
approach that aims to reduce organ dysfunction and the surgical
stress response, reducing morbidity and length of hospital stay [5].
One important aspect of an enhanced recovery programme is the
peri-operative information and patient education, which appears
to be essential in achieving early discharge [6,7].
We carried out a controlled, randomized trial in which we
compared patients treated by an ERAS approach to patients treated
in a standard care pathway [6]. The main objective of the present
sub-study was to evaluate patients receiving a planned stoma. We
wanted to investigate whether an ERAS programmewith dedicated
ERAS and stoma nurse specialists focusing on counselling and
stoma education can reduce the length of hospital stay, re-
admission, and stoma-related complications and improve health-
related quality of life (HRQoL) compared to current stoma educa-
tion in a traditional standard care pathway.
2. Material and methods
2.1. Study design
The current study was part of a randomized controlled trial at
Haukeland University Hospital in Bergen, Norway [6]. The aim was
to determine whether an ERAS care pathway can reduce the total
postoperative hospital stay (THS) compared to standard care,
mainly as a result of reduced morbidity. Patients who were to
receive a stomawere randomly divided in ERAS care with extended
stoma education, and standard care with conventional stoma ed-
ucation. Patients older than 18 years of age scheduled for elective
open or laparoscopic colorectal surgery for benign or malignant
disease and planned stoma were eligible for inclusion. Patients
with rectal cancer and pre-operative pelvic radiation were also
included. Patients were informed about the study both in writing
and orally, and written consent was obtained from those who
accepted to participate. Patients were informed about the treat-
ment group 1e3 weeks before surgery. Due to the nature of the
study, neither the physician nor the patient was blinded to the
treatment assignment. The trial was approved by the regional
committee of ethics in Western Norway (reference number 2010/
2079).
In the current sub-study, we wanted to focus on patients who
were planning to have a stoma as part of their surgical treatment
and were likely to be self-sufficient in managing their stoma. Pa-
tients who already had a stoma before the operation were not
included.
2.2. Objectives and endpoints
The primary endpoint was the THS which was defined as the
postoperative hospital stay (PHS), in days, and any additional days if
re-admission was necessary within the first 30 days after surgery.
The discharge criteria were similar for both treatment groups: (1)
postoperative pain adequately controlled with per oral medication
(VAS <4), (2) mobilized and out of bedmore than 6 h/day, (3) bowel
function and ability to tolerate solid food without nausea, and (4)
no complications requiring treatment in hospital. Furthermore, all
patients had to be comfortable with the stoma care based on an
agreement between theward nurse, the stoma nurse specialist, and
the patients themselves that they were proficient enough.
Secondary endpoints were PHS, major or minor morbidity,
mortality, early stoma-related complications, re-admission rate,
and HRQoL. Data were recorded before the operation, on the day of
surgery, and daily after surgery until discharge. Definitions of
complications were established prior to commencing the study.
HRQoL was assessed using the 15D instrument (http://www.15d-
instrument.net/15d), which is a standardized, self-administered
health state descriptive questionnaire that has been validated and
translated into Norwegian and can be used both as a profile and a
single index score measure [8]. The 15D includes dimensions of
mobility, vision, hearing, breathing, sleeping, eating, speech/
communication, excretion, usual activities, mental functioning,
discomfort and symptoms, depression, distress, vitality, and sexual
activity, with five levels on each. The single index score (15D score)
representing the overall HRQoL on a scale of 0e1 (1 ¼ full health,
0 ¼ being dead) and the dimension level values of 0e1 (1 ¼ no
problems on the dimension, 0 ¼ being dead) are calculated from
the health state descriptive system using a set of population-based
preferences or utility weights. The minimum clinically important
change/difference in the 15D score is 0.015 [9].
All patients visited an outpatient clinic on days 10 and 30,
following up with the same stoma nurse specialist and the same
two surgeons tominimize observer-related bias. The occurrences of
previously undescribed stoma-related complications were noted
during regular outpatient follow-up by the stoma nurse specialists
after 12 weeks.
2.3. Peri-operative education and care
Patients in the ERAS group had one or two consultations
45e60 min in duration before surgery with the ERAS nurse and
stoma nurse specialist. The patients were told about their own role
in retraining so that they understood the importance of their own
efforts and received thorough information about stoma surgery and
training in stoma care. The explanation provided to the patients
included the part of the intestine that was to be removed and the
consequences it may have, they were shown pictures of a stoma,
and the function of stoma care equipment was explained. Pre-
operative stoma education included the possible impact of stoma
creation on relationships and sexuality and various activities of
daily life, such as bathing and showering. The routines after surgery
were explained, the first shift being on the first postoperative day
with daily changes in order to get used to and build up skills and
confidence. Patients were also shown how to and practised
changing a stoma, told where to buy stoma care equipment, and
informed about the Norwegian patient association for stoma pa-
tients, Norilco. They received stoma care equipment to take home
for practice and received an information brochure to read.
Patients in the standard group received their first information
about the stoma from nurses with varying experience in stoma care
on the day of admission, which was the day before surgery. Patients
were told the part of the intestine to be removed and informed
about the shift routines, life with a stoma, bathing and showering
with a stoma, and Norilco.
In both groups, the stoma site was marked the day before sur-
gery. After surgery, the patients in the standard care group received
daily education from ward nurses, supervised sporadically by a
stoma nurse specialist. In the ERAS group the patients received
daily education from a stoma nurse specialist.
Patients in the ERAS group were treated according to the ERAS
protocol, whereas patients allocated to standard care were treated
according to standard peri-operative care in Norway [6]. The
numbers of ERAS items used in both groups are shown in Table 1.
During hospitalization, the patients in the ERAS group were
admitted to a ward separate from the standard group. The
responsible nurse in the ERAS group was a stoma nurse specialist
who also provided pre-operative education. Nurses in the standard
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care group were nurses experienced in the care of patients un-
dergoing colorectal surgery, including stoma care.
2.4. Statistical analysis
Statistical analysis was performed using IBM SPSS Statistics 22.
Descriptive statistical methods were used to characterize the
sample and data were presented as median and range. To compare
discrete variables the chi-square test was used. The independent
sample t-test was used for continuous, normally distributed out-
comes and the Mann-Whitney U test for continuous, non-normally
distributed outcomes. Paired sample t-test was used to detect sig-
nificant changes in the 15D score from baseline to 10 days and 30
days in the two groups and an ANOVA regression was applied to
compare differences in the change in the 15D score from baseline to
30 days between the groups.
This study was registered with ClinicalTrials.gov, no.
NCT01610726.
3. Results
Between January 5, 2012, and March 4, 2015, 122 patients who
received a planned stoma were included. The relevant patient
characteristics and surgical details of patients who received a
planned stoma are provided in Table 2. Baseline characteristics
were similar in both treatment groups. The types of stoma are
provided in Table 3.
3.1. Hospital stay and complications
The THS for patients receiving a stoma was significantly shorter
in the group randomized to ERAS and peri-operative stoma edu-
cation than the standard group (median [range], 6 days [2e21
days] vs. 9 days [5e45 days]; p < 0.001; Table 4). Regarding
overall, major, and minor morbidity, re-operation rate, re-
admission rate, and 30-day mortality, the two treatment groups
exhibited similar outcomes (Table 5). A considerable proportion of
patients experienced stoma complications, 38% in the ERAS group
and 51% in the standard care group (Table 6, p ¼ 0.15). Peristomal
dermatitis was the most common complication, but more severe
complications such as high output stomas with dehydration and
renal failure (S-creatinine > 100 mmol/L) were frequent.
Comparing ileostomies and colostomies in both groups, signifi-
cantly more complications occurred with ileostomies (Table 7,
p < 0.001).
3.2. Health-related quality of life
Themean 15D score at baselinewas 0.871 in the ERAS group and
0.870 in the standard care group. No significant difference was
found between the groups in any dimension level value or the 15D
score at baseline, 10 days, or 30 days. Both groups had significant
and clinically important deterioration in the 15D score from base-
line to 10 days (ERAS: -0.0868, p < 0.001; standard care: -0.0910,
p < 0.001) and significant and clinically important improvement in
the 15D score from 10 days to 30 days (ERAS: 0.0273, p ¼ 0.001;
Table 1
Numbers of ERAS items used in both groups [6].







Antimicrobial prophylaxis V V
Perioperative
Fluid restriction V
Anaesthetic protocol TIVA Gas
Prevention of hypothermia V V
Epidural anesthesia V V
Minimal invasive incisions
Postoperative
No routine use of nasogastric tubes V V
No use of drains in colon surgery V V
Enforced postoperative mobilisation V
Enforced postoperative feeding V
No systemic morphine use V
Standard laxative V
Early removal of urine catheter V
Total number 16 5
TIVA: total intravenous anesthesia.
Table 2
Patient characteristics and surgical details for patients who received a planned
stoma.
ERAS care Standard care p-value
Included patients 61 61
Median age (range), years 64 (23e88) 66 (19e89) 0.68a
Male/female, n/n 34/27 41/20 0.19b
Malignant/benign, n/n 56/5 57/4 0.73b
ASA, n (%) 0.84b
I 10 (16.4) 12 (19.7)
II 42 (68.8) 39 (63.9)




Left-sided or sigmoid 6 (9.8) 3 (4.9)
Low anterior resection 23 (37.7) 25 (41.0)
Abdominoperineal
resection (APR)
28 (45.9) 26 (42.6)
(Procto)-colectomy 4 (6.6) 7 (11.5)
Laparoscopy, n (%) 19 (31.1) 13 (21.3) 0.22b
Open surgery, n (%) 42 (68.9) 48 (78.9)
Conversion, n (%) 2 (10.5) 0 (0)
Median duration of
surgery (range), minutes
193 (111e432) 197 (102e367) 0.87a




Types of stoma used in each patient group.
ERAS care (n ¼ 61) Standard care (n ¼ 61)
Protective loop ileostomy
after LAR (or IPAA), n
24 (2) 27 (3)
Protective loop
colostomy after LAR, n
1 1
End ileostomy, n 2 4
End colostomy, n 34 29
LAR: low anterior resection; IPAA: ileal pouch-anal anastomosis.
Table 4
Postoperative data.
ERAS care Standard care p-valuea
Total hospital stay for planned stoma,
median days (range)
6 (2e21) 9 (5e45) <0.001
Postoperative hospital stay for
planned stoma, median days (range)
5 (2e12) 9 (5e24) <0.001
a Mann-Whitney U test.
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standard care: 0.0322, p ¼ 0.004). According to an ANOVA regres-
sion analysis, with age, gender, and baseline 15D score standard-
ized, there was no difference between the groups regarding the
change in 15D score from baseline to 30 days.
4. Discussion
This prospective study revealed a significantly shorter hospital
stay for patients treated with ERAS care and stoma education than
patients receiving standard care for stoma after colorectal surgery.
The two treatment groups did not differ in regards to mortality,
major or minor morbidity, stoma complications, re-operations, re-
admissions, or HRQoL within the first 30 days. To minimize the
possibility of confounding the treatment effect, patients in the two
treatment groups were located in two different wards that were
completely separated with different nursing personnel. All patients
in the ERAS groupweremonitored daily by a dedicated stoma nurse
specialist. To minimize observer-related bias, all outpatient visits
on days 10 and 30 were carried out by the same stoma nurse
specialist and the same two surgeons. They also performed all
prospective data registration.
4.1. Hospital stay
This sub-study analysis was done to evaluate the effect of pre-
and postoperative education for stoma patients within an ERAS
programme. Very little published research has analyzed the rela-
tionship between pre-operative education and length of hospital
stay for patients receiving a planned stoma in colorectal surgery. A
recently published systematic review of educational interventions
for stomas found only five studies evaluating the length of hospital
stay [4]. Of the five studies, two reported a reduction [2,10] and
three found no difference in length of stay [3,11,12]. Only two of
the studies were randomized controlled trials with few patients
[2,11], and one of them evaluated education as part of an enhanced
recovery programme [11]. Three studies reported rates of re-
admission, and none found a significant difference in re-
admission rates between groups [3,11,12]. Thus, our knowledge
of the effect of educational efforts in stoma patients combined
with ERAS on hospital stay is limited and we think that our study
makes an important contribution to the knowledge in this field.
4.2. Stoma related complications
Some retrospective and prospective studies, have reported a
reduction in stoma-related complications among patients who
underwent pre-operative stoma site marking and education
[13e16]. Two prospective studies did not find a significant differ-
ence in complications [3,11]. Only one of these studies was ran-
domized and few patients were included [11]. In our study, a high
number of stoma-related complications were observed. We care-
fully registered complications prospectively. Although there was a
tendency for fewer stoma-related complications in the ERAS group,
the difference was not significant. The fact that stoma sites were
marked by a stoma nurse specialist the day before surgery in both
patient groups may have influenced the results, but we think it
would be unethical to risk suboptimal stoma placement. Even if this
study included a large number of patients, it might not be suffi-
ciently powered with regard to the study question, as this was not
the main focus.
Half of the patients with ileostomy had peristomal dermatitis
that required treatment with crystal violet or local steroids, and 18%
had high output with dehydration and S-creatinine > 100 mmol/L.
Few data are available in the literature, but one review article from
2009 reported peristomal dermatitis in 5e25% of patients with
Table 5






Overall morbidity < 30 days 29 (50.8) 37 (60.7) 0.15
Patients with one or more
major complications




0/28 (0) 0/30 (0) 1.00
Abdominal wall dehiscence 1 (1.6) 0 (0) 0.32
Other complications
requiring re-operationb
1 (1.6) 1 (1.6) 1.00
Other major complicationc 1 (1.6) 0 (0) 0.32
One or more minor complications 29 (47.5) 36 (59.1) 0.20
Wound infection, abdominal 1 (1.6) 4 (6.6) 0.17
Wound infection, perineal 7 (25) 9 (34.6) 0.44
Intra-abdominal infection, antibiotic
treated or drainage
2 (3.3) 1 (1.6) 0.55
Prolonged postoperative ileus 1 (1.6) 5 (8.2) 0.09
Pneumonia 1 (1.6) 3 (4.9) 0.31
Cardiac arrhythmia 0 (0) 2 (3.3) 0.15
Urinary infection 7 (11.5) 9 (14.8) 0.59
Urine retention 7 (11.5) 13 (21.3) 0.14
Gastrointestinal bleeding not
requiring intervention
1 (1.3) 0 (0) 0.32
Renal failure (S-creatinine >
100 mmol/L)
5 (8.2) 5 (8.2) 1.00
Hyponatraemia (S-sodium <
130 mmol/L)
0 (0) 2 (3.3) 0.16
Postoperative confusion 1 (1.6) 0 (0) 0.32
Other minor complicationd 3 (4.9) 0 (0) 0.08
Re-operation 2 (3.3) 1 (1.6) 0.56
Re-admission < 30 days 13 (21.3) 11 (18.0) 0.62
Mortality < 30 days 1 (1.6) 0 (0) 0.32
a c2 test.
b Postoperative bleeding, deep abdominal infection.
c Sepsis.
d Paraesthesia in arm after laparoscopy, antibiotic treated infection of unknown
cause, transient ischaemic attack with normal MRI. Data are presented as n (%).
Table 6






Patients with one or more
stoma complications, n (%)
23 (37.7) 31 (50.8) 0.15
High output with dehydration
and S-creatinine>100 mmol/L, n
4 6
Stoma necrosis, n 0 1
Prolonged ileus due to stoma, n 1 0
Peristomal dermatitis, n 9 11
Peristomal dermatitis
due to high output, n
5 7
Peristomal dermatitis
due to stoma leakage, n
3 5
Stoma separation, n 2 3
a c2 test.
Table 7






Patient with one or more
stoma complications (%)
39 (68.4) 15 (23.1) <0.001
High output with dehydration
and S-creatinine>100 mmol/L
10 0
Stoma necrosis 1 0
Prolonged ileus due to stoma 0 1
Peristomal dermatitis 15 5
Peristomal dermatitis due to high output 10 2
Peristomal dermatitis due to stoma leakage 4 4
Stoma separation 2 3
a c2 test.
H.M. Forsmo et al. / International Journal of Surgery 36 (2016) 121e126124
ileostomies, and significant dehydration in up to 20% [17]. In our
study ileostomies had significantly more complications than co-
lostomies, and severe complications (e.g., high output with dehy-
dration and S-creatinine > 100 mmol/L) in colostomies were rare.
Readmission due to high output ileostomy remains a significant
concern in patients who have a newly formed ileostomy. Specific
education around this issue was not provided but will be part of
future improvement.
4.3. Health related quality of life
In this study no significant differences were observed be-
tween the two treatment groups in HRQoL within the first 30
days. To the best of our knowledge, only two studies have eval-
uated stoma education and HRQoL [18,19]. In a systematic review
from 2012, only these two studies were found and only one was
in English [20]. Both of these studies reported an improvement in
HRQoL, but patients admitted for education had a previous stoma
for several months. Therefore, it may be hard to decide whether
the improvement is due to education or simply time. We noted a
significant and clinically important improvement in the 15D
score from 10 days to 30 days, indicating adoption of the stoma
by the patient. The current study also demonstrates that patients
have equal HRQoL if they are discharged after 5 or 9 days (PHS).
In the important properties (reliability, validity, discriminatory
power, and responsiveness to change), the 15D compares at least
equally, often favourably, to the other preference-based generic
instruments such as EQ-5D, HUI3, and SF-6D [8,21e23]. In
contrast to disease-specific instruments, such as EORTC, com-
parisons of HRQoL are possible across different diseases and
conditions.
4.4. Stoma education and counselling
One important component of ERAS care is pre-admission in-
formation and counselling. This study evaluated stoma education
as part of an ERAS care pathway, which can make it difficult to
identify education as an independent effect. We cannot determine
how much of the reduced hospital length is due to ERAS care and
how much is due to stoma care education and the extended
counselling in general. It might be that the ERAS protocol is more
powerful in those with a stoma. To answer this question a 2  2
factorial design would be necessary and substantial more patients
would be required. The main benefit of extended pre-operative
counselling and stoma education was that the patients were
more responsive and capable of being taught directly after the
operation. However, the results of this study do not enable us to
conclude that counselling and stoma education or one other ERAS
item is more effective than other interventions. The ERAS approach
consisted of a package of interventions implemented differently
between the ERAS and standard care groups but equally within
each of them with very little or no variation with respect to single
interventions. This study design is appropriate for evaluating the
package of interventions but not to compare interventions.
Consequently, we cannot expect that a multivariate model
comparing the effects of single interventions will lead to mean-
ingful and interpretable results.
4.5. Study limitations
A limitation of this study was that we did not measure days to
stoma independence and proficiency. The study had predefined
discharge criteria, and the patients should be considered proficient
in managing their stoma. A randomized trial studying the effects of
intensive community-based pre-operative stoma education found
proficiency in management of the stoma after a median 5.5 days,
whereas the PHS was a median 8 days [2]. The reason for this large
difference between the date of stoma proficiency and the date of
dischargewas not given. In our opinion, insufficient proficiency and
lack of comfort with managing the stoma prolongs hospital stay
among stoma patients when there are otherwise no complications
requiring treatment in the hospital. In our study, patients with
surgical complications resulting in a longer hospital stay were not
excluded.
5. Conclusions
In summary, this prospective trial revealed a high frequency of
stoma-related complications, but the length of stay after elective
colorectal surgery with the need for stoma creation can be reduced
significantly with peri-operative education and guidance by dedi-
cated stoma nurses as part of an ERAS care pathway.
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Introduction
Standard elective colorectal resection is usually associated 
with a postoperative length of hospital stay of 6 to 12 days, 
and complication rate varies between 10% and 50% 
(Bokey et al., 1995; Schoetz et al., 1997; Vlug et al., 2011). 
Important factors for late recovery and discharge are post-
operative pain, paralytic ileus, and organ dysfunction 
related to surgical stress, but many other factors also play 
a role, such as immobilization, postoperative cognitive 
dysfunction, and local hospital traditions such as nasogas-
tric tubes, drain, and urinary catheter postoperatively. 
Perioperative care has been improved in the last 20 years 
with development of minimally invasive surgery, newer 
anesthetic and analgesic techniques, and other factors to 
reduce the surgical stress (Kehlet & Dahl, 2003; White 
et al., 2007). Enhanced recovery after surgery (ERAS) is a 
multimodal approach that aims to optimize perioperative 
management (Fearon et al., 2005). The ERAS program is 
a package of evidence-based changes in preoperative, 
intraoperative, and postoperative care to reduce organ dys-
function and surgical stress response to promote rapid 
recovery (Kehlet, 2008; Ren et al., 2012). ERAS guide-
lines were first published for colorectal surgery and in 
recent years also for other major procedures in gastrointes-
tinal surgery, urology, and gynecology, and include mostly 
around 15 to 20 perioperative elements. The key elements 
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Abstract
Aim: Enhanced recovery after surgery (ERAS) is a multimodal approach that aims to optimize perioperative 
treatment. Whether elderly patients receiving colorectal surgery can adhere to and benefit from an ERAS approach 
is uncertain. The aim of this study was to compare patients in different age groups participating in an ERAS program. 
Method: In this substudy of a randomized controlled trial, we analyzed the interventional ERAS arm of adult 
patients eligible for laparoscopic or open colorectal resection with regard to the importance of age. Patients were 
divided into three groups based on age: 65 years (n = 79), 66-79 years (n = 56), and 80 years (n = 19). The 
primary end point was total postoperative hospital stay (THS). Secondary end points were postoperative hospital 
stay, postoperative complications, postoperative C-reactive protein levels, readmission rate, mortality, and patient 
adherence to the different ERAS elements. All parameters and measuring the adherence to the ERAS protocol 
were recorded before surgery, on the day of the operation, and daily until discharge. Results: There were no 
significant differences in length of THS between age groups ( 65 years, median 5 [range 2-47] days; 66-79 years, 
median 5.5 [range 2-36] days; 80 years, median 7 [range 3-50] days; p = .53). All secondary outcomes were similar 
between age groups. Patient adherence to the ERAS protocol was as good in the elderly as it was in the younger 
patients. Conclusion: Elderly patients adhered to and benefited from an ERAS program, similar to their younger 
counterparts.
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of an enhanced recovery pathway are (a) extended patient 
information, (b) preservation of gastrointestinal function 
(carbohydrate solution before surgery, early enteral feed-
ing), (c) minimizing organ dysfunction (omission of 
mechanical bowel preparation, goal-directed fluid therapy, 
avoidance of drains and nasogastric tube, minimally inva-
sive surgery), (d) active pain control (opioid-sparing anes-
thesia and analgesia, local anesthetic infiltration of 
incisions), and (e) promotion of patient autonomy with 
early mobilization (Adamina, Kehlet, Tomlinson, 
Senagore, & Delaney, 2011). The more ERAS elements 
are implemented, the more frequently the postoperative 
course is improved (Gustafsson et al., 2011). Studies have 
demonstrated that ERAS is safe and shortens the length of 
the hospital stay (Adamina et al., 2011; Varadhan et al., 
2010). However, elderly patients have either been excluded 
or the sample size has been too small to perform subgroup 
analyses (Bagnall et al., 2014). There is also uncertainty as 
to whether elderly patients can comply with the imple-
mentation of this multidisciplinary program and whether 
they have better or worse outcomes in such a program than 
younger patients.
We have earlier conducted a controlled, randomized 
trial in which we compared patients treated with an 
ERAS approach with patients treated with a standard of 
care pathway (Forsmo et al., 2016). In this substudy of 
this prospective trial, the main objective was to evaluate 
patients in different age groups in the ERAS care path-
way and to see whether elderly patients achieved the 
same outcomes as younger patients. We also wanted to 
evaluate elderly patients’ adherence to an ERAS pro-
gram compared with younger patients.
Method
Study Design
The present study was based on data from a prospective 
clinical trial, which was undertaken at Haukeland 
University Hospital in Bergen, Norway, between 
January 5, 2012, and March 4, 2015. The aim of the 
study was to assess whether it was possible to decrease 
the length of total hospital stay (THS), mainly as a 
result of reduced morbidity. Detailed information 
regarding the study design and perioperative care is 
described elsewhere (Forsmo et al., 2016) . In brief, 
patients aged 18 years who were scheduled for elec-
tive laparoscopic or open colorectal surgery for malig-
nant or benign disease, with or without stoma, were 
eligible for inclusion in the study. One to 3 weeks before 
surgery, patients were informed about the study both 
orally and in writing, and written consent was obtained. 
Patients undergoing a planned multivisceral resection 
or with American Association of Anesthesiologist 
(ASA) score IV were excluded. Additional exclusion 
criteria were emergency operations, impaired mental 
capacity with difficulty providing informed consent, or 
inability to adapt to the ERAS criteria as evaluated by 
the study surgeons. If the intended colonic or rectal sur-
gery was not performed for any reason, the randomized 
patients were excluded from the analysis. Patients were 
randomized to ERAS or standard of care, and a ran-
domization list with an allocation ratio of 1:1 was gen-
erated with block randomization.
In this substudy, we focus on patients in the inter-
vention arm (ERAS group) of this randomized, con-
trolled trial and the influence of age on the ERAS 
program. Patients were divided into three groups 
based on age: 65 years (n = 79), 66-79 years (n = 56), 
and 80 years (n = 19). The numbers of ERAS items 
used are shown in Table 1. Adherence to all these 
items is dependent on physicians (surgeons, anesthesi-
ologists), nurses, physical therapists, and the patients 
themselves. The ERAS pathway intends to provide all 
ERAS elements to all patients as far as possible. The 
same physicians and nurses treated all patients, and 
thus, provider-depending differences between the age 
groups are highly unlikely.
Objectives and Endpoints
THS, measured in days, was the primary end point of this 
analysis. THS was defined as postoperative hospital stay 
(PHS) plus any additional days of readmission within the 
first 30 days after surgery. Equivalent discharge criteria 
were applied to all age groups. These included bowel 
function (feces or repeated flatus), mobilized and out of 
bed more than 6 hr each day, postoperative pain 
Table 1. Numbers of ERAS Items.
ERAS care
Preoperative
 Preoperative counseling  
 Preoperative feeding
 Carbohydrate loading





 Anesthetic protocol TIVA
 Prevention of hypothermia
 Epidural anesthesia
 Minimal invasive incisions  
Postoperative
 No routine use of nasogastric tubes
 No use of drains in colon surgery
 Enforced postoperative mobilization
 Enforced postoperative feeding
 No systemic morphine use
 Standard laxative
 Early removal of urine catheter
Total number 16
Note. ERAS = enhanced recovery after surgery; TIVA = total 
intravenous anesthesia;  = ERAS item completed.
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adequately controlled with oral medication (Visual 
Analog Scale < 4), and no complications requiring treat-
ment in hospital. Secondary end points were postopera-
tive complications, PHS, readmission rate, postoperative 
C-reactive protein (CRP) levels, mortality, and patient 
adherence to the different ERAS elements. CRP levels 
reflect the postoperative inflammatory response. Prior to 
study commencement, the definitions for complications 
were established and the incidences of complications 
were recorded in accordance with the Clavien–Dindo 
classification (Dindo, Demartines, & Clavien, 2004).
All parameters and measurements of adherence to the 
ERAS protocol were recorded by one study nurse and 
one surgeon before surgery, on the day of the operation, 
and daily until discharge. All patients had an outpatient 
clinic visit on Postoperative Days 10 and 30, which were 
all performed by one dedicated nurse and the same two 
surgeons.
Statistical Analysis
Statistical analyses were performed using IBM SPSS 
Statistics software, version 22. The different age groups 
in the ERAS care pathway were analyzed using descrip-
tive statistical methods, and the results of continuous 
variables were presented as the median and range. 
Discrete variables were compared with the chi-square 
test. For continuous outcomes, ANOVA and regression 
analysis (linear, quadratic, cubic, and exponential) were 
performed.
This study was registered with ClinicalTrials.gov 
(No. NCT01610726), and the local regional committee 
of ethics approved this trial (reference no. 2010/2079).
Results
In the main study, 329 of 653 eligible patients were not 
included, mainly because of a lack of capacity at the 
ERAS outpatient clinic, and 324 patients were ran-
domly assigned to the ERAS program or standard of 
care. Among 298 patients not included in the study 
(Figure 1), the percentage of patients over the age of 80 
was higher than those included in the study (23.1% vs. 
12.3%, respectively). In the patient group younger than 
65 years, this percentage was lower (41.3% vs. 51.3 %, 
respectively) (Figure 1). The patient characteristics 
and surgical details for patients included in this analy-
sis are summarized in Table 2. A greater proportion of 
patients in the two oldest age groups had ASA 3, and 
the proportion of patients with malignancy was higher. 
In patients aged <65 years, more rectal operations were 
performed.
There were no significant differences in THS between 
age groups treated in the ERAS program (Table 3). The 
ability to tolerate solid food without nausea did not dif-
fer between the groups. There were no differences 
between groups regarding postoperative CRP levels. 
Regression analysis with age as a continuous variable 
did not show any correlation between age and the out-
comes variables either.
The age groups exhibited similar outcomes regarding 
overall, major, and minor morbidity; reoperation rate; 
readmission rate; and 30-day mortality (Table 4). 
Complications according to Clavien–Dindo 3b did not 
differ significantly between the groups.
Adherence to the ERAS protocol is summarized in 
Table 5. Although total oral intake on the day of surgery 
was somewhat lower in patients aged 80 years, there 
Figure 1. Flow chart of patients considered for inclusion.
Note. ERAS = enhanced recovery after surgery.
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were no significant differences in intraoperative fluid load, 
intravenous fluid, total oral intake, or mobilization after 
surgery. Furthermore, there were no differences in the 
number of patients with preoperative counseling, omission 
of bowel preparation, intake of carbohydrate-loaded 
drinks before surgery, omission of preoperative fasting 
and premedication, postoperative laxative, thoracic epi-
dural analgesia, type of anesthesia, prevention of hypo-
thermia, and days to removal of the urinary tract catheter.
Discussion
The goal of this substudy was to evaluate the short-term 
outcomes of elderly and younger patients undergoing 
open and laparoscopic colorectal surgery using an ERAS 
protocol, and to see whether elderly patients could 
adhere to an ERAS program. Our main findings were 
that elderly patients equally adhered well to and benefit-
ted from an ERAS program as younger patients accord-
ing to the main outcome of reduced length of hospital 
stay. As the original study was a randomized trial, we 
believe that our results are based on a representative 
selection of patients who met the inclusion criteria.
A number of prospective and retrospective studies 
have demonstrated a similar length of stay when older 
and younger cohorts are compared (Baek et al., 2013; 
Kahokehr, Sammour, Sahakian, Zargar-Shoshtari, & 
Hill, 2011; Keller, Lawrence, Nobel, & Delaney, 2013; 
Table 2. Characteristics and Surgical Details of Patients Assigned to ERAS Care in the Different Age Groups.
Age group
 65 years 66-79 years 80 years p value
Included patients, n 79 56 19  
 Median age (range), years 58 (23-65) 72 (66-78) 83 (80-89)  
 Male/female, n/n 47/32 25/31 11/8 .22a
 Malignant/benign, n/n 58/21 47/9 19/0 .02a
 ASA, n (%) <.001a
  I 27 (34.2) 11 (19.6) 0 (0)  
  II 48 (60.8) 35 (62.5) 10 (52.6)  
  III 4 (5.0) 10 (17.9) 9 (47.4)  
 Type of colorectal surgery, n (%) .04a
  Right-sided 12 (15.2) 20 (35.7) 3 (15.8)  
  Left-sided or sigmoid 13 (16.5) 10 (17.8) 5 (26.3)  
  Low anterior resection 31 (39.2) 17 (30.4) 5 (26.3)  
   Protective ileostomy or colostomy 17 5 2  
  Abdominoperineal resection 17 (21.5) 9 (16.1) 6 (31.6)  
  (Procto)-colectomy 6 (7.6) 0 (0) 0 (0)  
 Laparoscopy, n (%) 35 (44.3) 18 (32.1) 9 (47.4) .37a
 Open surgery, n (%) 44 (55.7) 38 (67.9) 10 (52.6)  
 Conversion, n (%) 3 (8.6) 4 (22.2) 1 (11.1)  
 Median duration of surgery (range), minutes 177 (96-380) 154 (76-292) 172 (104-432) .14b
 Median blood loss (range), mL 200 (0-1500) 150 (0-1050) 200 (0-700) .80b
Note. ERAS = enhanced recovery after surgery; ASA = American society of anesthesiologists.
a 2 test.
bANOVA test.






(n = 19) p valuea
Total hospital stay, days 5 (2-47) 5.5 (2-36) 7 (3-50) .53
Postoperative hospital stay, days 5 (2-30) 5 (2-21) 6.5 (3-50) .22
Tolerated solid food without 
nausea, days
2 (0-8) 2 (0-9) 1 (0-6) .13
Median CRP levels, mg/L
 Preoperative 2 (1-42) 3 (1-18) 3 (1-35) .44
 Day 2 postoperative 110 (19-400) 137 (25-284) 154 (75-499) .30
 Day 10 postoperative 8 (1-136) 13 (1-216) 16 (4-206) .054
Note. Data are presented as median (range). ERAS = enhanced recovery after surgery; CRP = C- reactive protein.
aANOVA test.
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Pawa, Cathcart, Arulampalam, Tutton, & Motson, 2012; 
Senagore et al., 2003; Verheijen, vd Ven, Davids, Vd 
Wall, & Pronk, 2012; Walter et al., 2011), while other 
studies found longer length of stay in older patients 
(Feroci et al., 2013; Hendry et al., 2009; Rumstadt et al., 
2009). Two randomized controlled trials comparing 
ERAS with standard of care in elderly patients found 
significantly reduced length of hospital stay in patients 
allocated to ERAS care (Jia et al., 2014; Wang et al., 
2012). However, the definition of various age groups 






(n = 19) p valuea
Overall morbidity <30 days, n (%) 32 (40.5) 23 (41.2) 10 (52.6) .62
Patients with one or more major complications, n (%) 7 (8.9) 9 (16.1) 2 (10.5) .30
Major complications, n (%)  
 Anastomotic leakage/patients with an anastomosis 4/61 (6.6) 5/46 (10.9) 1/10 (10.0) .65
  Colon 2/25 (8.0) 1/29 (3.4) 0/5 (0) .65
  Rectum 2/36 (5.6) 4/17 (23.5) 1/5 (20) .15
 Abdominal wall dehiscence 1 (1.3) 3 (5.4) 1 (5.2) .36
  Other complications requiring reoperationb 2 (2.5) 0 (0) 0 (0) .39
  Other major complicationc 3 (3.8) 2 (3.6) 1 (5.3) .59
Patient with one or more minor complications, n (%)d 26 (32.9) 19 (33.9) 8 (42.1) .65
Reoperations, n (%) 7 (8.8) 8 (14.3) 2 (10.5) .61
Readmission <30 days, n (%) 12 (15.2) 14 (25.0) 4 (21.1) .33
Mortality <30 days, n (%) 0 (0) 2 (3.6) 1 (5.3) .18
Clavien–Dindo  Grade 3b, n (%) 25 (31.6) 14 (25.0) 8 (42.1) .36
Clavien–Dindo  Grade 3b, n (%) 7 (8.9) 9 (16.1) 2 (10.5) .40
Note. ERAS = enhanced recovery after surgery; ICU = intensive care unit.
a 2-test.
bOther complications requiring reoperation: postoperative bleeding, deep abdominal infection, iatrogenic bowel perforation, mechanical ileus 
requiring reoperation.
cOther major complication: cerebral vascular accident, gastrointestinal bleeding requiring endoscopic intervention, respiratory complications 
requiring ICU, sepsis.
dMinor complications: Wound infection (abdominal), wound infection (perineal), intraabdominal infection (antibiotic treated or drainage), 
prolonged postoperative ileus, pneumonia, pleural effusion requiring drainage, pulmonary embolism, cardiac arrhythmia, urinary infection, urine 
retention, gastrointestinal bleeding not requiring intervention, renal failure (S-creatinine >100 μmol/L), hyponatremia (s-Sodium <130 mmol/L), 
postoperative confusion, paresthesia of arm after laparoscopy, port site bleeding, pleuritis, subcutaneous infections, antibiotic treated infection 
unknown cause, early stoma related complications, transient ischemic attack with normal MRI. There were no significant differences in the 
subgroups of minor complications in the three groups of age.






(n = 19) p valuea
Day of surgery
 Intraoperative fluid loading, litersb 2.9 (1.2-5.7) 2.7 (0.9-5.5) 3.1 (1.8-4.6) .28
 Total oral intake after surgery, liters 0.6 (0-3.0) 0.6 (0-1.7) 0.4 (0-1.9) .07
Mobilization 24 hr after surgery, minutes 180 (0-360) 180 (5-420) 120 (0-360) .30
Intravenous fluid, liters
 First 24 hours, included intraoperative 3.8 (1.9-7.6) 3.9 (2.3-9.5) 4.8 (2.6-6.4) .59
 First 7 days, included intraoperative 5.2 (1.9-16.4) 4.9 (2.6-19.2) 6.4 (3.6-11.9) .80
Total oral intake, liters
 POD 1 1.6 (0.5-3.2) 1.6 (0.8-3.1) 1.4 (0.3-3.0) .23
 POD 2 1.6 (0.5-3.3) 1.5 (0.5-3.5) 1.7 (0.9-2.9) .39
Removal of urine catheter, days 3 (1-14) 2(1-21) 3 (1-6) .98
Removal of thoracic epidural analgesia, days 2.5 (0-5) 2 (0-4) 3 (1-4) .72
Mobilization, minutes
 POD 2 240 (15-540) 225 (30-420) 240 (30-360) .72
 POD 3 300 (30-660) 240 (60-540) 240 (60-360) .76
Note. Data are presented as median (range). ERAS = enhanced recovery after surgery; POD = postoperative day.
aANOVA test.
bIntraoperative fluid loading included 800 ml antibiotics.
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differed widely in all these studies. In our study, there 
were no significant differences in THS between the age 
groups. However, THS in the age group 80 years was 2 
days longer than in the age group <65 years. There were 
no differences in morbidity or 30-day mortality which 
could explain this difference. It was not possible to 
determine other factors contributing to this difference. 
This may be due to logistical challenges, such as home 
care situation, or the patient’s own wishes. Elderly 
patients are often living alone which implies that they 
have to be fit enough to manage their home situation by 
themselves. Even if discharge criteria are fulfilled, 
elderly patients may not be fit enough and have to wait 
for nursing home placement. This is in line with others 
who found that older patients remained in hospital for 
further 3 to 5 days after they met the criteria for safe 
discharge (Rumstadt et al., 2009). It might be a limita-
tion of our study that we did not measure days until dis-
charge criteria were fulfilled, but only THS.
As expected, patients in the oldest cohort in our study 
had more comorbidities and a higher proportion of 
malignancies than the younger age groups. Age is the 
single highest risk factor for developing cancer, and 
older patients are more likely to have malignant than 
benign tumors (Parks, Rostoft, Ommundsen, & Cheung, 
2015). Decision making regarding surgery in elderly 
patients is challenging because these patients have more 
comorbidities as well as functional and cognitive impair-
ments. The proportion of patients aged 80 years not 
included in the study was higher compared with the 
other age groups. This could represent a selection bias 
toward inclusion of more fit patients in the oldest age 
group, and exclusion of those who were considered frail 
and unable to adapt to the ERAS criteria as assessed by 
the study surgeons. This might reflect that a subgroup of 
elderly patients is not suitable for an ERAS program, 
although this may also be the case in younger frail 
patients. Interestingly, however, frailty does not neces-
sarily exist in patients with many comorbidities, and 
some elderly patients with little or no concomitant dis-
ease appear to be frail (Fried et al., 2001). We did not 
apply frailty risk stratification in our analysis, for exam-
ple, by “Comprehensive Geriatric Assessment” or 
“Fried criteria,” and therefore, we cannot state the pro-
portion of frail patients in the different age groups. The 
length of stay in the oldest age group may have been 
favorably influenced by the significantly increased pro-
portion of patients undergoing hemicolectomies and the 
reduced proportion undergoing rectal resections com-
pared with younger patients (Table 2).
No differences in morbidity and 30-day mortality 
were found between the age groups. A recently pub-
lished systematic review of ERAS care after colorectal 
surgery in elderly patients found 11 studies comparing 
older and younger cohorts (Bagnall et al., 2014). Seven 
out of the 11 studies found no difference in mortality 
(Baek et al., 2013; Hendry et al., 2009; Keller et al., 
2013; Naef, Kasemodel, Mouton, & Wagner, 2010; 
Rumstadt et al., 2009; Senagore et al., 2003; Walter 
et al., 2011). Two studies did not report on mortality, and 
two found higher 30-day mortality in patients aged >80 
years (Feroci et al., 2013; Pawa et al., 2012). In five 
studies, the complication rates were similar (Baek et al., 
2013; Hendry et al., 2009; Keller et al., 2013; Senagore 
et al., 2003; Walter et al., 2011); two studies did not 
report complications; and four studies found more com-
plications in older patients (Feroci et al., 2013; Naef 
et al., 2010; Pawa et al., 2012; Rumstadt et al., 2009). 
However, the definitions of the elderly age groups in the 
studies included in the review varied considerably, rang-
ing from ages >65 to 80 years. We divided the patients 
into three age groups to see whether there were differ-
ences between those aged 65 to 79 years and those aged 
80 years compared with younger patients. Considering 
the low number of patients aged 80 years, we could 
have divided the patients in two age groups instead of 
three. However, we think it would not be appropriate to 
dichotomize the patients into age groups above or below 
65 years, which often is done. On the contrary, we think 
that our grouping reflects the various age groups who 
undergo colorectal resections properly with regard to 
their physical characteristics and different stages of life. 
This view is supported by regression analysis with age 
as a continuous variable that did not reveal any correla-
tion between age and the outcomes variables. In elderly 
patients, there is greater heterogeneity regarding comor-
bidities and the degree of mobility. Treatment decisions 
and the choice of surgical intervention should therefore 
be based on biological characteristics rather than chron-
ological age. Thus, chronological age should not be a 
determinant in itself. The term frailty, which includes 
decreased reserves in general and deterioration in mul-
tiple organ systems, has been introduced. The frailty 
evaluation is important to avoid over- and undertreat-
ment, which is a well-known pitfall in geriatric oncol-
ogy (Ommundsen et al., 2014). Currently, there are no 
simple tests available to predict postoperative outcome 
for frail elderly patients. The Comprehensive Geriatric 
Assessment is recognized as the best tool for evaluating 
elderly patients preoperatively (Feng et al., 2015; 
Kristjansson et al., 2010). Unfortunately, it is time-con-
suming and might be difficult to use in a busy surgical 
clinical practice (Ugolini et al., 2015). It seems, how-
ever, reasonable that this extra time spent in identifying 
and treating correctable conditions in complex patients 
may decrease postoperative complications and length of 
hospital stay. As a consequence of this study, in collabo-
ration with our anesthesiologists, we will implement a 
tool for evaluating frailty in patients.
Adherence to the ERAS approach means to which 
extent the patients are able to implement the ERAS pro-
gram. Conducting an ERAS program depends on both the 
provider (surgeons and nurses) and the patient. Staff must 
facilitate that patients can implement the program. 
Adherence is measured by the extent of individual ERAS 
elements carried out. Previous studies have demonstrated 
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good compliance with preoperative and intraoperative 
ERAS elements, but reduced adherence during the postop-
erative phase (Hendry et al., 2009; Maessen et al., 2007). 
However, it has been suggested that compliance with post-
operative rather than preoperative ERAS elements is likely 
to be of particular importance for good progress and accel-
erated postoperative recovery (Maessen et al., 2007). 
Postoperative variables are markers of recovery and proto-
col compliance. Early mobilization is central in an 
enhanced recovery protocol. In a multivariate analysis, 
Hendry et al. (2009) identified age >80 years and higher 
ASA score as independent predictors of prolonged mobili-
zation. In our study, we found no differences in compli-
ance to the various ERAS elements between the different 
age groups. Also, no difference was found in the level of 
mobilization in contrast to other studies that have reported 
differences in levels of mobilization (Hendry et al., 2009; 
Pawa et al., 2012; Rumstadt et al., 2009). This may be 
related to the strict inclusion criteria among the oldest 
patients. We feel that it is highly likely that more elderly 
patients would benefit from special supervision and the 
guidance of specialist nurses in ERAS, particularly the 
postoperative ERAS elements, even if it is not possible to 
implement the entire program.
As expected, the elderly cohort in our study had more 
comorbidity and more malignancies than the younger 
age group. Elderly patients with more comorbidities 
might be expected to have higher rates of mortality and 
complications and experience longer hospital stays than 
younger patients. Our results show the safety of the 
ERAS program in elderly patients who are able to adapt 
to the ERAS criteria. We believe that more elderly 
patients should receive such perioperative treatment, 
and it is highly likely that they will have similar length 
of stay and the same rate of postoperative readmissions 
and complications as the younger patients.
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